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A STRUCTURAL AND MECHANISTIC STUDY OF TWO MEMBERS OF CUPIN FAMILY PROTEIN

by

FANGE (KATHERINE) LIU

Under the Direction of Dr. Aimin Liu

ABSTRACT
Cupin superfamily is a functionally diverse large group of proteins sharing a jelly roll β-barrel
fold. An enzymatic member 3-hydroxyanthranilate-3,4-dioxygenase (HAO) and a non-enzymatic member
pirin, which is a human nuclear metalloprotein of unknown function present in all human tissues, were
selected for structural and functional studies in this dissertation work. HAO is an important enzyme for
tryptophan catabolism and for 2-nitrobenzoic acid biodegradation. In this work, seven catalytic
intermediate were captured in HAO single crystals, enabling for the first time a nearly complete
structural snapshot viewing of the entire molecular oxygen activation and insertion mechanism in an
iron- and O2-depedent enzyme. The rapid catalytic turnover rate was found achieved in large part by
protein dynamics that facilitates O2 binding to the catalytic iron, which is bound to the enzyme by a
facile 2-His-1-carboxylate ligand motif. An iron storage and chaperon mechanism was also discovered in
the bacterial source of this enzyme, which led to a proposed novel biological function of a mononuclear

iron-sulfur center. Although human pirin protein shares the same structural fold with HAO, its iron ion is
coordinated by a 3-His-1-carboxylate ligand motif. Pirin belongs to a subset of proteins whose members
are playing regulatory functions in the superfamily. In this work, pirin is shown to act as a redox sensor
for the NF-κB transcription factor, a critical mediator of intracellular signaling that has been linked to
cellular responses to pro-inflammatory signals which controls the expression of a vast array of genes
involved in immune and stress responses.
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1.

CUPIN SUPERFAMILY

Cupin superfamily is a structure-based classification of a protein family. All the protein members
in this superfamily, although do not carry apparent sequence similarity, present an overall "jelly roll βbarrel” structural fold shown in Figure 1.1 by a few examples of the X-ray crystallographic data of the
cupin proteins. The β-barrel scaffold of cupins is constituted of four pairs of antiparallel β-barrel. This
superfamily was initially described by Jim M. Dunwell during studies of germins and plant storage
proteins (1). Later, it became clear that this superfamily was built on the same structural platform (2-4).
According to Pfam (http://pfam.sanger.ac.uk), cupin superfamily is the functionally most diverse
protein superfamily which contains more than 53 subfamilies with hundreds of thousands members
across all kingdoms of life. About one third of the total population of cupins is present with only one
cupin domain while the majority of the proteins contain two cupin domains.

Figure 1.1. Four representative cupin proteins: (A) Isopenicillin N synthase (PDB: 1QJE), (B)
superoxide dismutase (PDB, 2SOD), (C) oxalate oxidase (PDB: 1FI2) and (D) quercetin 2,3dioxygenase (1JUH). Pictures were drawn by using Pymol.
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Isopenicillin N synthase is the first structurally characterized protein in cupin superfamily (5).
Other well-characterized protein members include, but not limit to, Mn-containing oxalate oxidase

(germin) (6), Cu- or Fe-containing quercetin 2,3-dioxygenases (7-9), Fe- and Mn-superoxide
dismutases (SOD) (10). A subgroup of metabolic modulator proteins and gene transcription regulators
also belong to the cupin superfamily. However, these proteins are so far relatively poorly characterized.
Most, although not all, of the cupin proteins are metal-binding proteins. Cupins possess
characteristic of two short but highly conserved amino acid sequence motifs for binding a mononuclear
metal (Figure 1.2). In the absence of the structural information, the metal binding motifs shown in
Figure 1.2 are often used as cupin signatures. These two motifs collectively provide up to 3 histidine and
one glutamate residues for binding of a mononuclear metal ion, typically an Fe or a Cu, Mn etc.

Figure 1.2 Conserved consensus in cupin superfamily proteins

Although the overall protein fold is relatively unchanged from one member to another, the
metal center architecture varies and is only conserved for certain biological function. In this dissertation,
the research focus has been placed on the study of two of the cupin proteins. The first of which is 3hydroxyanthranilate-3,4-dioxygenase (HAO, also known as HAD), which is an important enzyme playing
roles in amino acid catabolism, NAD+ de novo biosynthesis, and toxic aromatic compound degradations.
The second cupin protein selected to study is a human nuclear metalloprotein, pirin, which is a nonenzymatic member of unknown biological function. These target cupins are Fe-containing proteins. The
initial protein structural information is available for both proteins (11, 12). The catalytic Fe in HAO is
coordinated with a facile 2-His-1-carboxylate ligand motif (13), whereas the Fe ion in pirin is bound more
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tightly to the protein with a 3-His-1-carboxylate motif. There are also apparent differences in the second
ligand sphere between the two cupin Fe centers.

2. UNDERSTANDING EXTRADIOL DIOXYGENASE MECHANISM in NAD+ BIOSYNTHESIS by VIEWING
CATALYTIC INTERMEDIATES

2.1. Abstract
The synthesis of quinolinic acid from 3-hydroxyanthranilic acid is a critical step in the de novo
biosynthesis of NAD+ from tryptophan in mammals. By performing time-resolved in crystallo reactions,
we observed a series of catalytic intermediates in a non-heme iron-based dioxygenase responsible for
quinolinic acid production. The catalytic mechanism is visualized by structural snapshots of seven
intermediates: mono- and then bidentate binding of the organic substrate, iron-bound superoxo,
alkylperoxo, epoxide, and two distinct conformations of the quinolinic acid precursors. A unique metalassisted cis/trans isomerization takes place in the oxygenated product to prevent it from forming
quinolinic acid prior to its release from the dioxygenase. These results, especially the epoxide

Figure 2.1 HAO occupies a central position in two biological catabolic
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intermediate, define a stepwise oxygen insertion for the dioxygenation important for NAD+ biosynthesis.
2.2 Introduction
Quinolinic acid (QUIN) is the universal precursor for de novo NAD+ synthesis across kingdoms of
life (14). In mammals QUIN is synthesized from the tryptophan metabolite 3-hydroxyanthranilic acid (3HAA) via an intermediary product α-amino-β-carboxymuconate-ε-semialdehyde (ACMS) in an enzymatic
step mediated by 3-hydroxyanthranilate 3,4-dioxygenase (HAO, also known as HAD or HAAO) (Figure
2.1). ACMS nonenzymatically cyclizes to yield QUIN (15). The dioxygenation reaction of 3-HAA for ACMS
production requires O2 and a non-heme Fe(II) ion bound in the center of a cupin structural fold in HAO
(11, 16-18). HAO functionally belongs to the extradiol dioxygenase superfamily, which cleaves an
adjacent non-hydroxylated carbon (meta-cleavage) rather than the carbon-carbon bond in between the
substitution groups. This is the most popular ring-cleavage reaction in nature. To date, extradiol
dioxygenase has more than 30,000 entries in the National Center for Biotechnology Information (NCBI)
protein database and three subtypes of the enzymes are known based on the evolutionarily distinct
structural folds (19).
A proposed oxygen activation and insertion mechanism is shown in Figure 2.2, which is based on
the model established for a remotely related extradiol dioxygenase superfamily member,
homoprotocatechuate 2,3-dioxygenase (2,3-HPCD) (20), theoretical studies (21-24), and the timeresolved X-ray protein crystallographic study presented below. Extradiol dioxygenases are highly
efficient biocatalysts. The reaction cycles typically complete within a millisecond. Thus, it has been
challenging to study the oxygen activation mechanism in this enzyme superfamily by the routine
spectroscopic methodology. Two key catalytic intermediate structures, superoxo and alkylperoxo with
its native substrate bound at the Fe center as well, have been characterized in 2,3-HPCD initially through
the in crystallo reactions (20), an extradiol dioxygenase superfamily member structurally and
evolutionally distinct from HAO. The superoxo intermediate is later to be confirmed by subsequent
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spectroscopic study (25). Similar intermediates are needed in an enzyme such as HAO to establish the
common oxygen activation feature in this superfamily. A noteworthy feature is that an active site acid
catalyst, typically a conserved histidine residue, is present in those well-characterized extradiol
dioxygenases to facilitate the O-O bond cleavage of the alkylperoxo intermediate to yield a gem diol
species (26). However, such an active site amino acid catalyst is missing in HAO, although the active site
structure does share most of the other common characteristics with other types of the extradiol
enzymes (see Figure 2.3).
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Figure 2.2 Crystal structure of HAO and the proposed catalytic cycle (A to J) based on the X-ray
time-resolved crystallographic study. (A) HAO, (B) 3-HAA-bound enzyme (monodentate), (C) 3HAA-bound enzyme (bidentate), (D) Fe3+-bound superoxo, (E) Fe2+-bound diradical (a resonance
structure of the superoxo), (F) Fe2+-bound alkyoperoxo, (G) Fe2+-bound epoxide or the resonance
structure Fe3+-bound epoxide radical, (H) Fe2+-bound ε-lactone intermediate, (I) Fe2+-bound ACMS at
the all-trans conformation, and (J) Fe2+-bound ACMS at the 2,3-cis-4,5-trans conformation.

Figure 2.3 A side-by-side comparison of the HAO active site and the 2,3-HPCD catalytic center (2IGA).
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2.3 Results and Discussion
In this work, important mechanistic questions such as (1) how is the organic substrate is binding
to the active site, (2) what is the relative orientation between the organic substrate and O2 in the
catalytic Fe center, (3) how do the two substrates interact with each other at the first contact, (4) will
the O-O bond be cleaved or the Fe-O2 bond, (5) what are the intermediary oxygenated intermediates,
and (6) what is the chemical conformation of the QUIN precursor, were asked and addressed
experimentally.
2.3.1 How does the organic substrate 3-HAA bind to HAO?
The general mechanism catalyzed by non-heme Fe-dependent enzymes typically starts with
chelation of the iron by the organic substrate, often a catechol compound. Substrate binding displaces
one or more solvent-derived metal ligands and causes reorganization of the iron coordination sphere to
open up a vacant site for the subsequent binding of O2. The ligand-free crystal structure of HAO from
Cupriavidus metallidurans was previously determined at 1.90 Å resolution, and the structure of the
enzyme in complex with 3-HAA was solved at 3.20 Å resolution (11). We obtained high quality single
crystals of Fe2+-HAO in an anaerobic chamber. The ligand-free crystal structure was determined in P6522
space group and refined to 1.74 Å resolution (Figure 2.2 inset, RCSB PDB deposition code: 4L2N). One
protomer was observed per asymmetric unit, and each interacts with another protomer in a neighboring
asymmetric unit giving rise to a homo-dimeric state (11). The catalytic iron is bound to the enzyme by a
2-His-1-Glu facial triad motif (Figure 2.4A). A second Cys4 iron-binding site at the surface of the enzyme
is also present for a non-catalytic protective role (27), which will be further studied in a separate effort
(Chapter 4).
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Figure 2.4. Active site structures of substrate-free (A, PDB entry: 4L2N) and substrate-bound HAO in
monodentate coordination (B, PDB entry: 4L2P) and in bidentate coordination (C, PDB entry: 4L2V).
The monodentate intermediate was trapped after < 30 s soaking of 3-HAA under O2-free conditions. The
2Fo-Fc maps are contoured at 1.0 σ. Atom color code: gray, carbon (protein residues); yellow, carbon
(ligand); blue, nitrogen; red, oxygen; magenta, iron.
To study the reaction cycle by X-ray crystallography, we performed time-resolved in crystallo
reactions in the absence (Figure 2.4) and presence (Figure 2.5) of O2. Thousands of crystals were
screened and about two hundred individual crystal diffraction data sets were collected and analyzed
structurally in distinct reaction time domains, about twenty at each time point. Representative
structures of seven distinct catalytic intermediates with full, or nearly full (≥ 95%), occupancy are
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presented below. These intermediates are generated in a relatively high reproducible manner at specific
incubation time intervals and pH, although they slightly vary due to the size differences of the crystals.
Under strict anaerobic conditions, two distinct binary complex structures were observed. An
unexpected structure of monodentate-ligated enzyme-substrate complex was observed by exposing
HAO crystals to the cryoprotectant containing 3-HAA for within 20 seconds. This structure was refined to
2.40 Å resolution (see Appendix Table A1) and deposited to the RCSB PDB with an entry code 4L2P. The
hydroxyl group of 3-HAA coordinates the catalytic ferrous ion with a bond distance of 1.7 Å, while the
amino group is 3.6 Å away from the Fe ion (Figure 2.4B). The 3-HAA is also in close contact with two
active site residues. Glu110 is H-bonded to the substrate hydroxyl group (2.7 Å) and Arg99 forms a salt
bridge with the carboxylate end of the substrate (3.9 Å). The carboxyl moiety of 3-HAA rotates out of the
phenyl ring plane due to its interaction with Arg99. This is the first structure of a monodentally ligated
enzyme-substrate complex of an extardiol dioxygease. In contrast, 30 seconds or longer 3-HAA
incubation resulted in a distinct yet anticipated ligand-bound structure (Figure 2.4C). The electron
density of the enzyme active site shows that the substrate binds to the iron with both the hydroxyl and
amino groups. The bidentately ligated complex was refined to 2.71 Å resolution (PDB entry 4L2V). Its
structure exhibits large resemblance to the previously published 3.20 Å resolution structure (1YFY.pdb)
with r.m.s.d value of 0.54 over 1254 Cα atoms included in the alignment. There is no additional electron
density observed for either O2 or water at the Fe ion in these two substrate-bound structures; forcing to
model O2 molecule resulted in negative density (Figure 2.6). Given the reproducibility, it is likely that the
monodentate ligation of the substrate is an intermediary state before final bidentate binding.
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Figure 2.5. Structures of dioxygen-incorporated intermediates after in crystallo reaction with
3-HAA and O2. (A) superoxo (~50 s, PDB entry: 4L2Q), (B) alkyoperoxo (~60 s, PDB entry: 4L2R),
(C) epoxide (3 - 5 min, PDB entry: 4L2S), (D) all-trans ACMS (~ 7 - 9 min, PDB entry: 4L2T), and
(E) 2,3-cis-4,5-trans ACMS (> 9 min, PDB entry: 4L2U). Atom color code: gray, carbon (HAD
protein residues); yellow, carbon (ligands); blue, nitrogen; red, oxygen; magenta, iron. Red
dashed lines represent hydrogen-bonding interactions (Å) while the gray dashed lines show
bonds or potential bonds to iron.
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2.3.2

Single crystals of HAO are catalytic active
In the presence of O2, the HAO-mediated ring-cleaving reaction which converts 3-HAA to ACMS

is a rapid process. The catalytic turnover rate is 25 s-1 (11), rendering trapping and characterization of
catalytic intermediates in solution after O2 binding infeasible. Additionally, the optical spectra of the
substrate, proposed intermediates and the reaction product are very similar to each other, which make
it challenging to follow by using electronic absorption spectroscopy and transient kinetics. In the current
study, we noticed that the single crystals of HAO were catalytically active with its native substrates,
albeit crystallized at pH 8.5 rather than the enzyme’s optimal pH, 7.0. In a quartz UV-Vis cuvette
containing single crystals of HAO with cryoprotectant, addition of 3-HAA under aerobic conditions
resulted in the conversion of 3-HAA to QUIN via ACMS (Figure 2.6). After the reaction, the single crystals
were still intact. Thus, this single crystal spectroscopic study shows that the single crystals are catalytic

Figure 2.6 Single-crystal UV-Vis spectroscopy. The catalytic reaction was performed with
seven single crystals of HAO in 450 µl cryoprotectant with seven single crystals of HAO. 3HAA (2 µM) was added into the cuvette aerobically and its enzyme-mediated decay to
QUIN was followed for 70 min. ACMS was observed as transient intermediate product.
Crystals survived after completion of the catalytic reaction. The maxima of UV absorption
of the substrate 3-HAA exhibits at 320 nm while the product ACMS shows absorbance at
373 nm at pH 8.5. The absorption of 3-HAA decreased at 320 nm concurrently with the
increase of the ACMS formation at 373 nm. ACMS is unstable and it non-enzymatically
cyclizes to QUIN, a transparent product, at a decay rate of 0.015 min-1 at neutral pH in
solution. When the pH level increases ACMS is prone to be more unstable, and the rapid
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competent.
2.3.3 Catalytically active ternary complex from O2 binding
To capture the catalytic intermediate in crystallo after O2 binding, we started to incubate the
crystalline enzyme with O2-saturated cryoprotectent containing 3-HAA. The first oxygenated
intermediate structure captured between 20 – 30 seconds is shown in Figure 2.5A. At this time interval,
we obtained multiple similar structures; the best X-ray diffraction dataset was used to refine an atomic
model against to 2.01 Å resolution (PDB entry: 4L2Q). 3-HAA alone cannot satisfy extra electron density
observed at the active site. Additional positive electron density was found in the anticipated O2 binding
site adjacent to the metal center and the bound 3-HAA (Figure 2.8A). This is the same site for O2, or
nitric oxide (NO), binding previously seen in the ternary complex structure of HAO, inhibitor 4-Cl-3-HAA
and O2 and the structure of HAO, 3-HAA and NO (11). Attempts to model only one oxygen or solvent
molecules resulted in extra electron density (Figure 2.8B).

Figure 2.7 Omit maps for 3-HAA bidentate-bound species molded using (A) superoxo species instead
of 3-HAA alone and (B) 3-HAA and water-ligated Fe center instead of 3-HAA alone. The blue 2Fobs – Fcalc
omit maps are contoured at 1.0 σ. The Fobs – Fcalc electron density maps are contoured at 3.0 σ and -3.0
σ in green and red, respectively.
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Figure 2.8 Omit maps for
dioxygen-incorporated Fe-bound
superoxo-species molded using
(A) 3-HAA instead of the superoxo
intermediate, (B) 3-HAA and one
oxygen atom modeled at the
adjacent side instead of the
superoxo, (C) epoxide instead of
the superoxo, (D) ACMS at the
early stage with all-trans
conformation instead of the
superoxo, and (E) ACMS at late
stage with 2,3-cis-4,5-trans
conformation instead of the
superoxo, respectively. The blue
2Fobs – Fcalc omit maps are
contoured at 1.0 σ. The Fobs – Fcalc
electron density maps are
contoured at 3.0 σ and -3.0 σ in
green and red, respectively.
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The ligand density around the Fe center cannot be modeled by later reactive intermediates
other than 3-HAA and an O2 ligand (Figure 2.8 C-E). In this intermediate, the organic substrate 3-HAA is a
bidentate ligand bound to the Fe in the opposite site of the protein ligands His51, Glu57 and His95, and
the O2 is bound to the iron in a typical end-on manner. Compared to the binary complex structures
obtained before O2 incorporation, an additional noteworthy feature for the bound substrate 3-HAA is
that its hydroxyl group rotates out of the ring plane, moving further close to the Glu110 residue. The
dioxygen is bound to the Fe in an end-on mode. The O-O bond, refined with no bond distance predefined, is 1.3(4) Å, and this is consistent with a superoxo species (20). Depending on the oxidation state
of the iron, this species can be one of the two resonance structures depicted in Figure 2.2 D and E, as
previously proposed in the 2,3-HPCD study (20). The out-plane rotation of the hydroxyl group in the 3HAA suggests that the organic substrate is already partially activated in this intermediate; as a result, it
facilitates the radical delocalization more prone to the C33-HAA – the carbon that the hydroxyl group is
attached to. This altered radical delocalization is a necessary step for forming next intermediate.
2.3.4 The oxygenated intermediates
The next oxygenated intermediate was trapped in flash-cooled crystals at 50 seconds after
mixing with O2-saturated cryoprotectant and 3-HAA, which was refined to 2.50 Å (PDB entry 4L2R).
Using the same refinement strategy applied to the prior intermediate, an intermediate similar to
superoxo was obtained (Figure 2.5B). A notable difference, however, between this later intermediate
and the prior superoxo is that this structure shows a much shorter distance between O2O2 to C43-HAA (2.3
compared to 3.5 Å), suggesting that an incipient bond is forming from the prior intermediate. This
species is consistent with an Fe(II)-alkylperoxo intermediate, and the distal oxygen atom of O2 has begun
to form a covalent bond with the organic substrate. The 1.76 Å length O-O distance is particularly
noteworthy as it is much longer than what it is normally observed 1.21 Å for O2 and 1.33 Å for superoxo
(28). Attempts to model this intermediate by the superoxo or other intermediates of the catalytic cycle
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resulted in obvious negative and/or positive densities around the iron center (Figure 2.8). In this
alkylperoxo intermediate, the substrate amino group is in an ideal position to function as an acid
catalyst to facilitate O-O bond cleavage. With metal chelation and increased hydrophobicity in the
enzyme, the pKa of the 3-HAA amino group would be significantly shifted. This observation provides a
plausible explanation for a missing active site acid catalyst.

Figure 2.9 Omit maps
for dioxygenincorporated Febound alkylperoxospecies molded using
(A) 3-HAA instead of
the alkylperoxo
intermediate, (B) 3HAA and one oxygen
atom modeled at the
adjacent side instead
of the alkylperoxo
species, (C) epoxide
intermediate instead
of the alkylperoxo,
(D) all-trans ACMS
instead of the
alkylperoxo, and (E)
2,3-cis-4,5-trans
ACMS instead of the
alkyloxo species. The
blue 2Fobs – Fcalc omit
maps are contoured
at 1.0 σ. The Fobs –
Fcalc electron density
maps are contoured
at 3.0 σ and -3.0 σ in
green and red,
respectively.
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Figure 2.10. Omit maps for Febound epoxide-species molded
using (A) 3-HAA instead of
epoxide, (B) superoxo-species,
(C) epoxide-species in short of
the proximal oxygen, (D) all-trans
ACMS, (E) 2,3-cis-4,5-trans
ACMS. The blue 2Fobs – Fcalc omit
maps are contoured at 1.0 σ. The
Fobs – Fcalc electron density maps
in A, B, D, and E are contoured at
3.0 σ and -3.0 σ in green and red,
respectively; The maps in C are
contoured at 3.3 σ and -3.3 σ in
green and red, respectively.
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At 5 minutes, a new species with external ligand at the iron center exhibits a highly constrained
conformation (Figure 2.5C). The distal oxygen of the dioxygen is incorporated to the 3-HAA between the
C3 and C4 carbon, forming a three-member ring epoxide while the proximal oxygen remains bound to
the Fe ion and is stabilized by Glu110 through H-bound interactions. The best dataset of this
intermediate was refined an atomic model against 2.40 Å resolution (PDB entry: 4L2S). Likewise,
attempts to model this dataset with other catalytic intermediate were unsuccessful (Figure 2.10). The
oxygen insertion to the organic substrate caused a substantial distortion of its phenyl ring; as a result,
the epoxide intermediate is far from planer but instead in a slightly distorted boat conformation. The
zoom-in view of epoxide of multiple viewing angles is shown in Figure 2.11. The epoxide oxygen is
stabilized by Arg47; a residue appears to be the companion of the distal oxygen atom till this step. We
attempted to analyze this species by other models. However, the Fo-Fc maps suggest that none of them
can fit the electron density (Figure 2.11). Among these improper models, epoxide without the proximal
oxygen bound to iron fits the electron density better than the others, except an extra electron density
demanding the presence of the proximal oxygen (Figure 2.8). The structural characterization of Febound epoxide intermediate makes it clear that the oxygen insertion is conducted in a stepwise manner,
rather than concerted, in this dioxygenase reaction. Though it has been predicted by theoretical studies
(21-24), this epoxide intermediate had not been observed or structurally characterized from any
dioxygenases.
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Figure 2.11 Additional views for the structures of the epoxide intermediate showing the boat
conformation.

2.3.5 The intermediate product bound HAO complexes
Seven minutes and longer reaction granted two intermediary product species (Figure 2.5 D and
E). In both structures, the aromaticity of the substrate 3-HAA is broken. The Fe center is bound with an
exogenous organic ligand in linear structural form in both intermediates and they are not identical to
each other (Figure 2.5 D and E). Modeling ACMS fitted well into the electron densities. In the
intermediate trapped after 7 - 9 min of the in crystallo reaction (refined to 2.06 Å resolution, PDB entry
4L2T), the well-defined electron density map shows that the ligand is an ACMS in its all-trans
conformation, with a newly formed carboxylate group bidentately coordinated to the iron and the
original amino group close to, but not coordinating the iron. In the second ACMS-bound structure, which
was obtained from longer reaction time (> 11 min), the product is in the 2,3-cis-4,5-trans conformation
(refined to 2.30 Å resolution, PDB entry 4L2U). Interestingly, the model was built by using the all-trans
ACMS as the starting ligand, but it ended up with a distinct conformation after fitting with the electron
density. The 2,3-cis-4,5-trans ACMS coordinates to the Fe in a bidentate manner by its oxygen atoms
from each carboxylate group, at the distance of 2.7 and 2.3 Å, respectively. Neither swapping the two
ACMS-bound models nor any other intermediates of Figure 2.2 fits the corresponding electron densities
(Figures 2.12 and 2.13). There is no final product QUIN-bound structure obtained in any of the hundred
structures solved from in crystallo reactions with a time frame up to two days. The 2,3-cis-4,5-trans
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ACMS and ligand-free HAO structures were observed in the crystals of those from prolonged reaction
times. Apparently, ACMS releasing appears to be the rate-limiting step in the in crystallo reaction.

Figure 2.12 Omit maps for Fe-bound ACMS at early stage with all-trans
conformation molded using (A) 3-HAA instead of ACMS, (B) superoxo-species, (C)
epoxide-species in short of the proximal oxygen, and (D) ACMS at the late stage with
2,3-cis-4,5-trans conformation, respectively. The blue 2Fobs – Fcalc omit maps are
contoured at 1.0 σ. The Fobs – Fcalc electron density maps are contoured at 3.0 σ and 3.0 σ in green and red, respectively.
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Figure 2.13 Omit maps for Fe-bound ACMS at late stage with 2,3-cis-4,5-trans
conformation molded using (A) 3-HAA instead of ACMS, (B) superoxo species instead of
ACMS, (C) epoxide species instead of ACMS, and (D) all-trans instead 2,3-cis-4,5-trans
ACMS, respectively. The blue 2Fobs – Fcalc omit maps are contoured at 1.0 σ. The Fobs – Fcalc
electron density maps are contoured at 3.0 σ and -3.0 σ in green and red, respectively.
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The ACMS-bound structures represent the first attempt to determine the crystal structure of an
unstable intermediary product in QUIN synthesis. Chemically, ACMS has many different conformations
as shown in the NMR study of an analogue compound (15). It was known that the all-trans form is the
most stable conformation of ACMS while the all-cis counterpart is the most likely form to autocyclize via
an electrocylic reaction (15), and also that the 2,3-trans-4,5-cis form is proposed to be the last isomer
prior to the all-cis. Interestingly, the ACMS made by HAO is in neither 2,3-trans-4,5-cis nor all-cis
conformation. Our results show that a metal-assisted cis/trans isomerization converts the all-trans to
the 2,3-cis-4,5-trans form for final release. This intermediary product is in a structurally remote
configuration from the anticipated 2,3-trans-4,5-cis form (Figure 2.2). Thus, the dioxygenase is
preventing ACMS from autocyclization so that it will not generate QUIN inside the enzyme and that a
portion may be safely taken or delivered to the active site of the downstream enzyme of the kynurenine
pathway, to avoid overproduction of QUIN, a compound which is excitotoxic causes excessive
stimulation of nerve cells at overwhelmed concentrations (29, 30). The kynurenine pathway partitions
for the fate of ACMS. A decarboxylase competes with the non-enzymatic reaction to direct the
metabolic flux to either acetyl-CoA (31, 32) or glutaryl-CoA (33). At pH 7.0 and room temperature, the
half-life time of ACMS is 43 min in our determination and this will be significantly shorter at higher pH
and temepratures. The HAO-assisted cis/trans isomerization is important for keeping enough noncyclized ACMS and this is likely part of a natural strategy to control the branched pathways while one
pathway reaction is enzymatic and the other is spontaneous and nonenzymatic .
An intriguing observation is that the ACMS automatically adjusts the orientation prior to its
departure from the catalytic iron. The metal-assisted trans-to-cis transition would not be able to take
place with a double bound presenting between the C2 and C3 of ACMS. In the newly formed ACMS, the
2,3-bond is not a double bond due to the bidentate ligation of the carboxyl and amino groups to the
iron. Thus, the enzyme completes such a transition and naturally, the amino group switches off from the
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metal and the carboxylate group becomes a metal ligand once the metal-assisted cis/trans isomerization
is complete. Although the all-trans conformation is the most stable form of ACMS, the constrain forces
resulted from the epoxide intermediate would make this metal-bound ACMS a transient species. Like
the monodentate ligated 3-HAA shown in Figure 2.4B, the all-trans ACMS is probably trappable only

Figure 2.14 Proposed NAD+ biosynthesis mechanism from 3-HAA (3-hydroxyanthranilic acid).
NaMN (nicotinic acid mononucleotide) and NaAD (nicotinic acid adenine dinucleotide) are the
intermediates from QUIN (quinolinic acid) to NAD+ (nicotinamide adenine dinucleotide).
because the reaction is in inside the crystal.
With a total of seven intermediate crystal structures and an improved enzyme-alone structure,
the current study provides support for the general oxygen activation characters of the Fe dioxygenase
and leads to comprehension for the first time the mechanism of QUIN production for NAD+ biosynthesis
(Figure 2.14). The model shown in Figure 2.2 is also the first mechanistic cycle for an extradiol
dioxygenase lacking the active site histidine for promoting O-O bond cleavage. The epoxide structure
has been proposed in both heme and non-heme dioxgenases as a key intermediate, such as hemedependent tryptophan dioxygenase (34-36), but has not been structurally characterized until this work.
The characterization of this intermediate provides the most solid evidence that a large fraction of the
dioxygenases performs oxygen atom transfer to the organic substrate in a stepwise fashion.
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Figure 2.15. Omit maps for all six of
the intermediates with assignment of
each claimed intermediate structure
(A) 3-HAA monodentately bound to
the Fe ion, (B) bidentate ligand, (C)
alkylperoxo, (D) epoxide, (E) all-trans
ACMS, (F) 2,3-cis-4,5-trans ACMS. The
blue 2Fobs – Fcalc omit maps are
contoured at 1.0 σ. The Fobs – Fcalc
electron density maps in A, B, D, and E
are contoured at 3.0 σ and -3.0 σ in
green and red, respectively; The maps
in C are contoured at 3.3 σ and -3.3 σ
in green and red, respectively.
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2.5 Further experimental details
Materials―3-hydroxyanthranilic acid, ammonium iron(II) sulfate (99.997%), ascorbate, and glycerol
were the highest grades purchased from Sigma-Aldrich and used without further purification.
Expression and purification―The HAO gene from Cupriavidus metallidurans was overexpressed in
Escherichia coli (DE3) cells (Novagen) and purified by nickel affinity chromatography as previously
described (7, 19). Purified protein was reconstituted with five equivalents of NH4Fe(SO4)2 anaerobically.
The resultant protein then underwent size exclusion column Superdex 200 which is equilibrated with
Tris-HCl buffer (10 mM, pH 7.6) containing 2 mM DTT and 5% glycerol.
HAO in crystallo reaction―Full length (1 – 174 amino acid) HAO proteins were crystallized by
optimization of conditions previously established using hanging drop vapor diffusion in VDX plates
(Hampton Research). Single crystals suitable for X-ray data collection were obtained from drops
assembled with 1 μL protein solution layered with 1 μL reservoir solution containing 0.1 M Tris pH 8.5,
0.2 M MgCl2, 1 mM DTT, 18% PEG 8000. Crystal growth took place in a vibration-free crystal growth
refrigerator from Molecular Dimensions at 16 °C. In order to trap the binary complex of enzyme and
substrate, the in crystallo reaction was firstly performed by exposing single HAO crystals in the solution
(0.1 M Tris-HCl pH 8.5, 0.2 M MgCl2, 20% PEG 8000) supplemented with 1mM 3-HAA in anaerobic
chamber. The 3-HAA monodentate-bound HAO was trapped by exposing single crystals with 3-HAA in
cryoprotectant within 20 seconds while the 3-HAA-chelated HAO was captured in exposing time of 30
seconds. The in crystallo reaction was then carried out with the cryoprotectant containing 3-HAA and
also being purged with O2 for 30 min prior to mixing with crystalline enzymes. The crystals were exposed
to the aforementioned reaction solution for different periods of time of 50 seconds, 1, 3, 5, 7 and 13
minutes. For each of the time scale, single crystals were mounted in small loops of fine rayon fiber and
flash-cooled directly in liquid nitrogen after being dipped into the cryoprotectant solution that
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contained 0.1 M Tris-HCl (pH 8.5), 0.2 M MgCl2, 20% PEG 8000 30% glycerol for individual structural
determination.
X-ray Data Collection and refinement―X-ray diffraction data were collected at the SER-CAT beamline
22-ID or beamline 22-BM at the Advanced Photon Source (APS), Argonne National Laboratory, Argonne,
IL. All data collection was performed at 100 K. The diffraction data was indexed, integrated and scaled
with HKL2000 (37). The structures were solved by molecular replacement using MOLREP (38) program of
the CCP4 suite (39) with holo-HAO (PDB accession number 1YFU) as search model. Link restraints to Fe
were removed from the refinement to avoid bias in the refined Fe-ligand distance. Electron density was
fitted and refined using Coot (40), Phaser (41) and REFMAC (42).
Ligand Refinement and molecular modeling―In order to avoid bias in model building, ligand
refinement was initiated at the final stage of the structure refinement by examining ligand-omit
difference maps. 3-HAA was employed as the initial ligand model for all intermediate structures and the
proper ligands were modeled into the density by checking on the Fobs – Fcal maps. The dictionaries for the
3-HAA derived Fe(II)-superoxo, alkylperoxo, epoxide, and ACMS intermediates were generated with
Phaser (41). Among the structures determined, some of which exhibit overlapping intermediate states
and the density cannot be fitted by one single intermediate structure. These overlapping structures
were excluded for further analysis because of heterogeneous nature. Only the intermediates with
ligands occupancy between 90 - 100%, including all the carbon, oxygen and nitrogen atoms, were
analyzed further. The structures with the best resolution in each intermediate are shown in the results.
The blue 2Fo-Fc maps resultant from the metal-ligands His51, Glu57 and His95 as well as active-site
ligand are contoured at 1.0 σ. Finally, the active site ligands were removed and the resultant ligand-free
structures were refined with five cycles of restrained refinement for preparation of the difference maps.
The resultant positive density (green) contoured at 3.0 σ is in agreement with the corresponding active
site ligand in all models (Figure 2.15). In the ligand-free enzyme (Figure 2.4A), we observed extra
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election density at the catalytic iron center which can be accommodated by two water molecules.
Strong spherical density is observed in the pocket created by residues Val41, Arg47, Pro97 and Arg99 at
the bottom of the substrate–binding cleft, and it is assigned to an Cl- anion. The presence of the Cl- is the
structural signature of the resting state of HAO enzyme in ligand-free form (11). Checking for the
presence of this Cl- anion and the occupancy of the candidate ligand were the two beginning steps in the
intermediate ligand refinement. Two distinct substrate-bound HAO structures (Figure 2.4B and Figure
2.4C) were obtained under anaerobic conditions by soaking argon-saturated O2-free 3-HAA in the
cryoprotectant. We initiated our ligand fitting with 3-HAA. After 3-HAA was modeled into the structure,
it became clear that no extra electron density for O2 around the catalytic iron center. To ensure that no
oxygen species present in these two structures, we also attempted to model dioxygen into these
structures. The fitting and refinement were performed exactly the same manner as what was carried out
on the oxygen-free ligand structure. The result revealed negative density at the site of the modeled
dioxygen, while the electron density on 3-HAA was undisturbed (for one of these, see Figure 2.6).
For the five dioxygen-incorporated structures presented in this study, ligand modeling was
initiated with 3-HAA as well, however, none of the active site in those intermediates contained 3-HAA in
an unaltered form. Sequentially fitting the density features with the candidate ligands proposed from
the mechanistic cycle was applied instead of using the non-crystallographic symmetry (NCS) restraints
refinement in the PHENIX suite (43). The candidate ligands include 3-HAA, 3-HAA-Fe-superoxo, 3HAA-Fealkylperoxo, Fe-epoxide intermediate and the ring-opening product, ACMS, in two distinct
conformations. Each of the candidate ligands was fitted into the data sets individually. These ligands
satisfied the respective extra electron density at the active site distinctly.
As discussed earlier, one dioxygen-incorporated species was assigned as Fe-bound superoxo
species of HAO. We refined this species with sole 3-HAA and it resulted in both positive and negative
electron densities around 3-HAA. In addition, the superimposition of the superoxo structure with either
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the determined monodentate-bound 3-HAA or bidentate-bound 3-HAA shows large differences at the
orientations of the metal-ligands and 3-HAA. Nevertheless, if only one oxygen atom is positioned
adjacent to 3-HAA, positive density is clearly revealed suggesting a missing oxygen atom. We further
fitted and refined with epoxide, ACMS at the early and late stage. However, none of them is able to
satisfy the extra electron density at the active site (Figure 2.8).
The fourth structure shown in the result section was assigned as an alkylperoxo intermediate.
Likewise, we attempted to fit and refine it with different ligands by using the same strategy as described
above. As shown in Figure 2.9, the green positive electron density adjacent to 3-HAA suggests a missing
oxygen atom or atoms in the structures of Figure 2.9 (A and B). When this species was assigned to an
epoxide intermediate, there was no density to cover the proximal oxygen (Figure 2.9C). The assignment
of this species to an ACMS also results in unsatisfied electron density (Figure 2.9 D and E).
The fifth structure shown in the main text was assigned as an epoxide intermediate. Figure 2.10
shows that none of the other catalytic cycle intermediates would satisfy the extra electron density at the
active site with the exception of the epoxide species. Moreover, if we fit the epoxide ligand without the
proximal oxygen, the positive density (green) appears (Figure 2.10C) and this unassigned density can be
satisfied by simply fitting the proximal oxygen back to the corresponding position. As we observed in
fitting to the 2,3-cis-4,5-trans conformation with Fe-bound all-trans ACMS, negative electron density
around the newly degenerated carboxyl group suggests mis-assignment.
The sixth structure shown in the main text was assigned as an iron-bound all-trans ACMS. As
shown in Figure 2.12, the extra electron density at the active site cannot be covered either by 3-HAA,
superoxo, epoxide and the 2,3-cis-4,5-trans ACMS which was trapped at a later stage.
The seventh structure shown in the main text was assigned as an iron-bound 2,3-cis-4,5-trans
ACMS. Fitting of different ligands was similarly performed as described above. Figure 2.13D shows the
fitting results of refining ACMS to the all-trans conformation to the structure. Positive electron density is
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observed at the amino moiety while the negative electron density at the newly generated carboxyl
group, suggesting such an assignment of the ACMS conformation is inconsistent to the experimental
data. The major difference in the electron densities between ACMS at the early and late stages (Figure
2.13) is the shift of the electron density of the original carboxyl group of the 3-HAA. This electron density
includes one carbon and two oxygen atoms. In contrast, the amino group has only electron density for
the nitrogen atom. The relative orientation of the carboxyl group and amino group is distinct in the
assigned confirmations. The bulky density belonging to the carboxyl group is away from the catalytic
iron in the all-trans ACMS structure whereas it is close to the iron in the 2,3-cis-4,5-trans ACMS
structure.
Reproducibility―We performed Ɵme-resolved in crystallo reactions with the native substrate of HAO
and O2. At each of the incubation time-scale, 20+ crystals were frozen down and structurally determined
through X-ray diffraction data collections and subsequent data analyses. Each of the catalytic
intermediates presented in the main text was also observed in additional structural data sets of various
resolutions. Among those, the binary enzyme-substrate complex and the product-bound enzyme were
easier to obtain because they are relatively stable with respect of other catalytic intermediates. The
product ACMS is unstable and thus it is not possible to perform soaking experiment to the crystalline
enzyme to compare with the in crystallo reaction results. Among the crystal structures determined at
the same time scale, the best-fit structures were chosen to represent the corresponding intermediates
based on the following criteria: 1) occupancy of each of the atoms in the catalytic intermediates is above
90%, 2) the positions of the carbon atoms are at the center of the electron density, 3) the refined
structure with the defined catalytic intermediate does not show apparently different temperature
factors with the surrounding amino acid residues, 4) the ligand presents sounded bond-lengths and
interactions among the intermediate and the surroundings. These criteria enabled us to rule out the
overlapping structures of the intermediates species.
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3. SUBSTRATE-INDUCED LOOP MOVEMENT IS ESSENCIAL FOR RAPID OXYGEN INCORPORATION IN 3HYDROXYGANTHRANILIAT 3,4-DIOXYGENASE

3.1 Abstract
3-hydroxyanthranilate dioxygenase (HAO) exists in the tryptophan degradation pathway in
eukaryotic species, a pathway which is responsible for energy production and NAD+ biosynthesis. It also
independently exists in the 2-nitrobenzoic acid degradation pathway in prokaryotic species for energy
supplementation. Crystal structures of HAO have been determined from multiple sources. The
substrate-bound structure shows a closed conformation in contrast to the open conformation. We
determined six more structures of HAO and the HAO variant, in substrate-free and substrate/inhibitorbound forms. These structures provide a clear depiction of ligand-induced loop movement in three
specific loop regions adjacent to the catalytic center. A significant increase in hydrophobicity at the iron
center is observed as the consequence of the concerted loop movements due to binding of the organic
substrate. Due to the inherent hydrophobic character of O2, such an increased Fe-center hydrophobicity
is proposed to be essential for rapid O2 binding and activation. Asn27 and Ile142 are identified as two
key residues to orchestrate the structural reorganization in response to the organic substrate’s binding.
A single mutation at Ile142 to alanine abolished the loop-movement. Taken together, these structural
studies provide a model to explain how the proficient non-heme Fe dioxygenases enrich O2 from bulk
solvent to fulfill a high catalytic rate.
3.2 Introduction
The ring-cleaving dioxygenase enzymes are abundant and versatile in nature (44). These enzymes
are proficient, with catalytic rate constants faster enough to escape spectroscopic characterization of
their catalytic intermediates. The activation of O2 in these enzymes is typically accomplished by a
mononuclear non-heme metal center to activate O2 (45). A fundamental question remain to be
answered is that how these enzymes are succeeded in a rapid O2 binding which is necessary for the
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observed catalytic rates while local O2 concentration in aqueous solution is at low levels (200 – 300 μM
at 1 atom pressure and room temperature).
Here, we chose a ring-cleaving dioxygenase as a model system for the study of this problem. 3Hydroxyanthranilate dioxygenase (HAO) is a non-heme iron-dependent extradiol dioxygenase belonging
to the cupin superfamily (11, 16, 17). This enzyme cleaves the phenol ring adjacent to the substitution
groups. It activates and inserts dioxygen across the 3,4-bond of its substrate 3-hydroxyanthranilate,
ultimately producing quinolinic acid via the intermediary product α-amino-β-carboxymuconate-εsemialdehyde (ACMS) (see Figure 2.1, Chapter 2). HAO is present in the kynurenine pathway of
eukaryotic organisms where it is essential for NAD+ biosynthesis and tryptophan degradation. It is also
found in the 2-nitrobenzoic acid (2-NBA) pathway of certain prokaryotes where it is responsible for ringcleavage for energy production.
HAO from Cupriavidus metallidurans has been shown to operate at a catalytic turnover rate of
25 s-1 (11, 27). We were curious how this enzyme enhances oxygen absorption at the catalytic center to
achieve this catalytic rate. Previous structural studies on HAO have allowed atomic level understanding
of the overall protein structure and the active site architecture (11, 16-18). A substrate-bound structure,
albeit at a low-resolution of 3.2 Å, is available to compare to the substrate-free structure (11). In order
to improve the quality of these structures, we have recently determined both the ligand-free structure
(1.70 Å resolution) and substrate-bound structure (2.70 Å resolution) refined them to better resolutions
(see Chapter 2).
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3.3 Result and Discussion
3.3.1 Induced open-to-close scenario is observed in HAO upon substrate-binding
Single crystals of wild-type HAO were obtained in an anaerobic chamber. They were washed by the
3-HAA-containing cryoprotectant under strict O2-free anaerobic conditions. This procedure generates
substrate-bound HAO structures with 3-HAA bidentately chelated to the catalytic Fe ion as described
previously. The superimposition of substrate-free and substrate-bound structures of wild-type HAO

Figure 3.1. A substrate-induced loop movement around the catalytic Fe center is observed in three
loop regions in HAO upon 3-HAA binding. (A) Substrate-free structure, (B) substrate-bound structure,
and (C) alignment substrate-free (yellow), substrate-bond (magenta). The well-aligned components
are shown in grey while the deviations are highlighted in colors. The metal iron is represented by a
sphere while substrate 3-HAA is shown in sticks. The electron density map was shown on the three
loop regions involved in the movement. The three loops of were fitted into the open conformation
(wheat). The 2Fo-Fc map is contoured at 1 σ; the Fo-Fc map is contoured at 3 σ (green) and -3 σ (red),
respectively. The three specific loops identified are as follows: Loop A,
Leu20Leu21Lys22Pro23Pro24Val25Gly26Asn27Arg28; Loop B,
shows that the enzyme exhibits two distinct conformations (Figure 3.1), which are termed open and
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closed states hereafter. The substrate-bound structure is in the closed state that exhibits significant
structural changes relative to the ligand-free open state on three specific loop regions surrounding the
catalytic Fe center (Figure 3.1). These loop regions are as follows:

Residues 21 – 28 (loop A): Leu20Leu21Lys22Pro23Pro24Val25Gly26Asn27Arg28)
Residues 41 – 47 (loop B): Val40Val41Gly42Gly43Pro45His46Arg47)
Residues 139 – 148 (loop C): Leu139Lys140Ser141I142Val143Thr144Asp145Leu146Pro147Pro148.

Most of these residues are highly conserved across the protein sequences of HAO from various
origins (Figure 3.2). These three loops shift towards to the active site iron upon 3-HAA binding. Among
these three loop regions, loop A undergoes the largest movement with a shift towards the active site of
ca. 8.6 Å in average for the carbon atoms when compared to the corresponding loop in the substratefree form. When the three loops are gathered to the Fe ion, the Fe center becomes significantly more
packed, resulted in an apparently a distinct active site conformation with respect to the more open
conformation observed in the enzyme alone structure. Loops A and C appear to function as doubledoors to the active site cavity.

33

Figure 3.2 Multiple HAO sequence alignment against the protein sequence of HAO from
Cupriavidus metallidurans (top).
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Figure 3.3 Monodentately bound 3-HAA in HAO is not able to induce the loop movement. Left, the
superimposition of the substrate-free structure and 3-HAA monodentately bound HAO structure is
shown. The well-aligned components are shown in grey while the deviations are highlighted in colors
(substrate-free, yellow; substrate-bound, forest). The metal ion is represented by a sphere while
substrate 3-HAA is shown in sticks. Right, the electron density map was shown on the three loop
regions involved in the movement fitted into the open conformation (forest, top) but not the closed
conformation (wheat, bottom), respectively. The 2Fo-Fc map is contoured at 1 σ; the Fo-Fc map is
contoured at 3 σ (green) and -3 σ (red), respectively.
The electron density of the residues found in the loop regions are shown in (Figure 3.3).
Attempts to fit the loop residues to the open conformation led to unsatisfactory results. The electron
densities do not align well on the loop residues in the open position. At a short incubation time window,
we obtained the crystal structure of 3-HAA monodentately bound HAO (PDB entry 4L2P, see Chapter 2
for details). The electron density of the active site clearly shows the 3-HAA monodentately bound to the
iron with the OH group at 1.7 Å while the NH2 lies at 3.1 Å away. Surprisingly, we did not observe the
loop movement as seen in the bidentate binding structure. The residues from loop A, B and C aligned
well with the electron density at open conformation. If the three loops are forced to fit into the closed
conformation, a lack of density at some of the residues, including xx, is clearly seen. The monodentate
structure is an intermediate step prior to the final bidentate chelation. The result indicates that only the
bidentate chelation of substrate is able to evoke the loop movement and close the active site.
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3.3.2 The chemical nature of the Fe center in the closed state
A salient feature is that all three loops are composed of mostly hydrophobic residues. Each also
contains one or two proline residues. Loop A and loop C also possess two consecutive proline residues
(i.e., Pro23Pro24 and Pro147Pro148, respectively). Proline is a cyclic hydrophobic residue and the
proline-proline dimeric fragment endows the loops with ring structure. Loop B is a highly hydrophobic
fragment composed of only one proline residue (Pro45). The local hydrophobicity of the Fe center will
be substantially increased due to movement of the three loops with respect to the ligand-free structure,
which will facilitates the migration of molecular oxygen to the Fe center at the active site and thus
maximize its catalytic efficiency.
3.3.3 Structural requirement to induce loop movement
We further sought for the driving force responsible for initiating the loop movement. After
careful comparison of the structures of substrate-free, substrate monodentately bound and substrate
bidentately chelated HAO, we found that the bidentate chelation of 3-HAA brings Asn27 closer to the
active site through hydrogen bonding interactions with the carboxylate group of 3-HAA (Figure 3.4).
Consequently, Ile142 was triggered to move closer to the iron center through ionic interactions. The
original distance between Ile142 and Asn27 is 7.8 Å and it is 8.4 Å between Ile142 and Asn27 in the open
state. The movement of Asn27 shortens the distance between Ile142 and Asn27 to 3.8 Å; allowing a salt
bridge to form in between. This salt bridge strengthens the interactions between Asn27 and Ile142 and
further induces the movement of loop C (Figure 3.4C). Furthermore, the movement of Asn27 initiates
movement in loop A: Pro24, one residue on loop A, which derives hydrogen bonding interactions with
Asn45 on loop B and evokes the movement of loop B. Monodentately bound 3-HAA is not able to induce
the loop movement due to the long distance (6.6 Å) between the carboxyl tail of 3-HAA and the nitrogen
group of Asn27. Without the proper positioning of Asn27, none of the movement in loops A, B or C can
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occur. The self-adjustment of 3-HAA to a bidentate chelation mode shortens the counterpart distance
by 2 Å, which results in the Asn migration to the active site. Therefore, the driving force for the loop
movement is the interaction between substrate carboxyl group and Asn27 and the interaction between
Asn27 and Ile142.

Figure 3.4 The relative positions of Asn27 and Ile142 and their interactions in the (A) substrate-free
HAO, (B) 3-HAA monodentate bound HAO, and (C) 3-HAA bidentate bound HAO. The three loop
regions involved in loop-movement are highlighted in color. Ile142, Asn27, Pro24, Asn45 and 3-HAA
are shown in ball-and-stick mode. The distances between two-atom pairs are measured in units of Å
and shown in dashed lines.
The salt bridge interaction between Ile142 and Asn27 is present in all of the HAO structures with
a closed state active site, including two structures bound with the suicide inhibitor 4-Cl-3-HAA and O2 or
NO which were determined previously (11). Both of the structures show a closed conformation with
three loops moving towards the active site iron. As expected, the interaction between the carboxyl tail
of 4-Cl-3-HAA and Asn27 brings the late party into the active site. These observations further validate
our conclusion that the loop movement is triggered by the 3-HAA-induced movement of Asn27 and
Ile142.
3.3.4 Single mutation at Ile142 breaks down the loop movement phenomenon
The salt bridge formed between Ile142 and Asn27 upon substrate binding functions as a “clamp”
and brings loops A and C towards the active site. The I142A variant has been previously constructed and
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Figure 3.5 4-Cl-3-HAA bound HAO structures also turn on the closed conformation (A)
superimposition of 4-Cl-3-HAA and O2 bound HAO ternary complex and ligand-free HAO (B)
superimposition of 4-Cl-3-HAA and NO bound HAO ternary complex and ligand-free HAO. The wellaligned components are shown in grey while the deviations are highlighted in colors (ligand-free,
yellow; 4-Cl-3-HAA plus O2 bound, raspberry; 4-Cl-3-HAA plus NO bound, hot pink). (C) 3-HAA
bidentately bound HAO. The three loop regions involved in loop-movement are highlighted in color.
Ile142, Asn27, O2, NO and 4-Cl-3-HAA are shown in ball-and-stick mode. The distances between twoatom pairs are measured in units of Å and shown in dashed lines.
shown to be nearly catalytically inactive. Clearly, Ile142 participates in the catalytic reaction although its
precise role in catalysis has not been explained. We hypothesize that it affects substrate (O2) binding
and reduces HAO catalytic efficiency. Due to the very low catalytic activity and the relative low
sensitivity of the oxygen electrode, the Km for O2 cannot be determined. To test whether the loop
movement phenomenon would still be observed with the removal of one salt bridge partner, we
crystallized this variant in substrate-free and the crystal structures of I142A in complex with 3-HAA, 2aminophenol (2-AP) and 3-aminosalicylic acid (3-ASA) and several product-bound catalytic intermediates
in crystallo. The crystal structure of the I142A variant was determined at 1.70 Å (Figure 3.6). The
comparison of the structure of I142A with the wild-type HAO structure revealed slight deviations on the
residues 141 – 147, but no obvious deviations over the whole structures including the metal ligands as
well as the second sphere residues as indicated by the root-mean-square deviation (RMSD) value of
0.141 from 1195 out of 1195 atoms. Thus, the observed reduction in the catalytic activity (kcat) in the
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mutant with substitution at Ile142 is not due to a global structural change but rather the structural
alteration of loop C.
3.3.5 Structure of the I142A-3-HAA complex
To test the role of Ile142 in substrate binding, the X-ray crystal structure of the I142A-3-HAA
complex was determined at 2.70 Å resolution (PDB pending). The electron density map reveals that 3HAA binds to the active site of I142A HAO in a bidentate chelation pattern which is similarly observed in

Figure 3.6 Structure details on I142A HAO. (A) Crystal structure of HAO I142A variant (PDB entry
pending); (B) Comparison of the active site environments of the I142A variant and the one in wild
type HAO (PDB entry 1YFY). The 2Fo-Fc s electron density map is contoured at 1.0 σ. Atom color
code: grey, carbon (wild type HAO); yellow, carbon (I142A-HAO); blue, nitrogen; red, oxygen;
yellow, iron (I142A); grey, iron (wild type HAO). (C) Crystal structure of I142A HAO variant in
complex with native substrate 3-HAA (PDB entry pending); (D) Comparison of the active site
environments of I142A variant in complex with 3-HAA and the one in wild type HAO in complex
with 3-HAA (PDB entry pending). The 2Fo-Fc electron density map is contoured at 1.0 σ. Atom color
code: grey, carbon (wild type HAO); yellow, carbon (I142A-HAO); blue, nitrogen; red, oxygen;
yellow, iron (I142A HAO); grey, iron (wild type HAO).
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wild-type HAO, Figure 3.3A. The superimposition of these two structures reveals several differences.
Although 3-HAA binds to the active sites in I142A and wild-type HAO both in a bidentate chelation
mode, substrate rotation is observed; an eight-degree dihedral angle formed by the phenol rings from
the substrates in the mutant and wild-type enzymes is revealed. At the same time, the metalcoordination ligands and several second-coordination sphere residues including Asp49, Arg47 and Arg99
show deviations in orientations when compare to the counterparts in the substrate-bound wild-type
structure. It is noteworthy that significant changes are observed in the previously defined mobile loop
regions; 3-HAA bidentately chelates the catalytic iron in I142A and does not induce the loop movement.
The loop regions can be well-aligned with the substrate-free structure (Figure 3.6). The salt bridge
between Ile142 and Asn27 is not observed from these mutant structures. The interaction between
Ile142 and Asn27 is presumably the key link to bring the loops together towards the catalytic iron. The
alteration in the I142A variant renders this hydrogen-bonding interaction impossible, thus we do not
observe the aforementioned loop movement even with the occurrence of proper substrate binding.

Figure 3.7 Single mutation of I142A disables the loop movement in HAO. (A) Superimposition of
structures of I142A HAO and 3-HAA bidentately bound I142A HAO (B) zoom-in view of the three loop
regions of I142A HAO (C) zoom-in view of the three loop regions of 3-HAA bidentately bound I142A
HAO. The three loop regions involved in loop-movement are highlighted in color. Ile142, Asn27 and
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3.4 Concluding Remarks
When the primary function of those Fe-dependent dioxygenase enzymes is to oxidize hydrophilic
organic compounds by activating the non-polar, symmetric, hydrophobic molecular oxygen, a difficult
decision has to be made: should the second ligand sphere of the Fe center be more hydrophilic or
hydrophobic? In this study, we show that nature has offered an intelligent solution to solve the riddle.
The Fe center is set to be more suitable for the binding of the organic substrate, and after that, a wellprepared protein dynamics follows to re-tune the active site to a much more hydrophobic environment
for attracting O2 to bind. To do this, the enzyme has to set an ordered substrate binding as found in
nearly all of the Fe-dependent oxygenases. Without the organic substrate-aided tuning, the active site
would not be ideal for binding of O2. An additional benefit is that the Fe(II) ion would not tend to be
oxidized by O2 when the primary organic substrate is absent, i.e., preventing enzyme autooxidation.
While nature has more than one strategy to solve the low oxygen concentration problem in
solution for a rapid oxygen consumption reaction at the enzyme active site, the unique feature of
protein dynamics induced by substrate binding reported here may be the first structurally defined
example for facilitating O2 binding to the catalytic Fe along with the primary organic substrate in each
catalytic cycle. With a rapid turnover rate, the O2 level could drop significantly after several seconds and
minutes of reaction, and the O2 diffusion to the solution may not be faster enough and thus cause a
seemingly hypoxia condition. If this occurs, the increased hydrophobicity would become more important
to attract O2 binding. Given the vast number of metal-dependent oxygen utilization enzymes, the
protein dynamic-hydrophobicity strategy may be one of natural popular strategies to direct molecular
oxygen towards organic substrate-bound metal centers.
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4.

THE RUBREDOXIN FE IS A SPARE TIRE TO THE CATALYTIC NON-HEME FE IN BACTERIAL 3HYDROXYANTHRANILATE-3,4-DIXOYGENASE

4.1 Abstract
3-hydroxyanthranilate-3, 4-dioxygenase (HAO) catalyzes the aromaticity-breaking oxidative
cleavage of 3-hydroxyanthranilate by use of a catalytic Fe(His)2Glu center, a reaction which is found
critical in the kynurenine pathway of eukaryotes and the 2-nitrobenzoic acid (2-NBA) pathway of some
prokaryotes. The 2-NBA pathway was recently discovered and thought to have evolved in response to
human activity, and the bacteria in which it is found are able to use it as their sole source of carbon,
nitrogen and energy. An interesting property of HAO from the bacterial 2-NBA pathway is a highly
conserved Fe(Cys)4 center which is not found in majority of the eukaryotic analogues. Here we show
through EPR, Mössbauer, and fluorescent spectroscopic characterization, as well as X-ray
crystallography that the buried catalytic center binds iron before the surface (Cys)4 site. We also found
with DALI structural search that the Fe(Cys)4-containing domain in HAO resembles those of some ironchaperon proteins. Following this finding, a doubling of enzymatic activity was observed from holo-HAO
after addition of a stoichiometric quantity of apo-HAO incubation with apo-HAO, which suggests that
iron bound to the (Cys)4 site can be transferred to the (His)2Glu site. The results showed here uncover a
new function of Fe(Cys)4 center to perform as iron chaperon domain.
4.2 Introduction
The massive scale of the industrial synthesis of chemicals has generated a number of
environmental challenges in recent decades. One major issue is the limited re-incorporation of synthetic
organic molecules into natural biological cycles. Notably, nitroaromatic compounds are released into the
biosphere almost exclusively from anthropogenic sources: agricultural and rubber chemicals, herbicides,
leather, paper, and sulfur dyes (46). Unfortunately, they are relatively resistant to biological degradation
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and recycling (47). 2-Nitrobenzoic acid (2-NBA) is prominent among these compounds, and it is also one
of the most common precursors of numerous toxic compounds in the environment (48). Due to the
amount of 2-NBA released into the environment in the past few decades a number of microorganisms
have evolved the ability to utilize it as their sole source of carbon, nitrogen, and energy (31). Previous
studies have shown that the bacterial degradation of 2-NBA begins with its conversion to 3hydroxyanthranilic acid (3-HAA) (49). From 3-HAA, the 2-NBA pathway shares the same catabolic
strategy and enzymes with the kynurenine pathway for L-tryptophan catabolism in eukaryotes (50).
3-Hydroxyanthranilate-3,4-dioxygenase (HAO, also known as HAD or HAAO) is the first of a
series of enzymes shared by both the 2-NBA and kynurenine pathways (31, 33, 51). This enzyme
catalyzes the critical aromaticity-breaking step of the pathways by activating dioxygen to oxidatively
cleave the phenyl ring of 3-HAA, producing α-amino-β-carboxymuconate-ε-semialdehyde (ACMS)
(Scheme 1) (15). ACMS is an unstable compound which spontaneously dehydrates and autocyclizes to
produce quinolinic acid (QUIN) with a half-life time (t1/2) of 46 min at pH 7.4 (52). The eukaryotic and
prokaryotic HAO proteins are likely to have arisen from a common ancestral gene. Not only is the same
chemical reaction catalyzed, but these proteins also share a significant degree of sequence identity (53).
HAO is a non-heme, iron-dependent, extradiol dioxygenase (54). The first crystal structure (11),
which was determined from Cupriavidus metallidurans reveals that this enzyme is a homodimer
belonging to the functionally diverse cupin superfamily (3, 4), and that the catalytic Fe is anchored by a
2-His-1-carboxylate facial triad ligand set (55). The crystal structures of HAO from eukaryotic origins are
now available from Saccharomyces cerevisiae (16), bovine kidney, and human (18). An unexpected
phenomenon is that prokaryotic and Saccharomyces cerevisiae HAO structures contain two separate
iron binding domains. The first is the (His)2Glu catalytic site which is the same as the catalytic site in
eukaryotes, and the other is a rubredoxin-like site coordinated by four cysteine residues on the protein
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Figure 4.1 Crystal structure of HAO from C. metallidurans (from 1YFU.PDB). The two metal
centers are represented as magenta spheres while the metal ligands are shown as sticks.

surface at the C-terminus which is not found in eukaryotes. The two iron centers are separated by 24 Å
as depicted in Figure 4.1.
The rubredoxin-like iron center found in prokaryotic and Saccharomyces cerevisiae HAO is not
involved in catalysis. Rather, it was shown in a previous study to be capable of absorbing leaking
oxidative equivalents and thus preventing destructive protein damage should an uncoupling of dioxygen
activation and substrate oxidation occur at the active site (54). This finding raises an immediate question
of why the vast majority of eukaryotic HAOs do not employ a similar iron center for the same purpose.
Here we propose that the Fe(Cys)4 center in prokaryotic HAOs functions as an endogenous iron
chaperon; it is able to store an additional iron ion which is used to replenish the catalytic center and
maintain catalytic sustainability in case of iron loss from the active site caused by competition from
other metalloproteins or chelation by metabolic intermediates. This role would be of paramount
importance for bacteria which use 2-NBA as their sole energy and carbon source.
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4.3 Materials and Methods
4.3.1 Chemicals.

57

Fe (95% enrichment) was obtained from Science Engineering and Education Co.

(Edina, MN). 3-HAA, ammonium iron(II) sulfate (99.997%), ascorbate, EDTA, copper sulfate pentahydrate
and glycerol were purchased from Sigma-Aldrich in their highest grades and used without further
purification.
4.3.2 Protein preparation for the HAO catalytic activity assays.
HAO from Cupriavidus metallidurans was purified according to the published method (11). The
metal-free apo form of HAO was prepared by overnight EDTA (10 mM) treatment, followed by dialysis
against fresh buffer (10 mM Tris-HCl pH 7.6). The fully loaded HAO (holo-HAO) was obtained by adding
10 equiv of Fe2+ to the apo form of HAO and the excessive free iron ions were removed by either dialysis
or desalting purification prior to use. The resulted HAO was reduced by ascorbic acid prior to enzyme
activity assays.
4.3.3 Catalytic activity measurement of adding apo-HAO to holo-HAO.
Holo-HAO was premixed with apo-HAO at different ratios ranging from 0 to 2 equivalents. The
catalytic activity of each sample was measured by monitoring the product formation at 360 nm. For
each sample, the residual activity from apo-HAO was deducted from the observed activity to determine
the effective activity for comparison. For each individual trace of a specific apo-HAO concentration, the
absorbance at the starting point was subtracted over the whole time course to correct for background.
4.3.4 Reconstitution of apo-HAO for Mössbauer measurements.
Under anaerobic conditions in a glove box, we recharged the apo-HAO with 57Fe2+, and/or Cu2+,
one equivalent at a time. This procedure generated a series of samples containing 57Fe/57Fe, 57Fe/Cu,
and Cu/57Fe. The 57Fe/57Fe -HAO was prepared by reconstitution of apo-HAO with 2.1 equiv of Fe2+ ion
under anaerobic conditions, followed by desalting separation using G25 column and O2-free argon-
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saturated buffer to remove unbound Fe ions. The 57Fe/Cu-HAO was prepared by reconstitution of apoHAO with 1.1 equiv of 57Fe2+ ion under anaerobic conditions and followed by addition of 1 equiv of Cu2+.
The Cu57Fe-HAO was prepared by reconstitution of apo-HAO with 1.1 equiv of Cu2+ ion under anaerobic
conditions and followed by loading of 1 equiv of 57Fe2+.
4.3.5 Mössbauer spectroscopy.
57

Fe-enriched HAO was obtained from apo-HAO reconstituted with 57Fe2+. The final protein

concentration was 0.9 mM. Mössbauer spectra were recorded on a constant acceleration instrument
with an available temperature range of 1.5 to 200 K. Isomer shifts are reported relative to Fe metal at
298 K.
4.3.6 Electronic paramagnetic resonance (EPR) spectroscopy.
The Cu2+-HAO EPR samples were prepared by reconstitution of apo-HAO with Cu2+ ion followed
by desalting on a G25 column. X-band EPR spectra were obtained in perpendicular mode on a Bruker
(Billerica, MA) EMX spectrometer at 100-kHz modulation frequency using a 4119HS high-sensitivity
resonator. Low temperature was maintained with an ITC503S temperature controller, an ESR910 liquid
helium cryostat, and a LLT650/13 liquid helium transfer tube (Oxford Instruments, Concord, MA).
4.3.7 X-ray data collection and crystallographic refinement.
HAO proteins were crystallized by optimization of conditions previously established using
hanging drop vapor diffusion in VDX plates (Hampton Research). Single crystals suitable for X-ray data
collection were obtained from drops assembled with 1 μL protein solution layered with 1 μL reservoir
solution containing 0.1 M Tris-HCl pH 9.0, 0.2 M MgCl2, 1 mM DTT and 20% PEG 8000. Crystal growth
was carried out at 16 °C in a vibration-free crystal growth refrigerator (Molecular Dimensions Ltd.). The
crystals were mounted in small loops of fine rayon fiber and flash-cooled directly in liquid nitrogen after
being dipped into the cryoprotectant solution (0.1 M Tris-HCl, pH 9.0, 0.2 M MgCl2, 22% PEG 8000 and
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30% glycerol). X-ray diffraction data of Fe/Cu-HAO and Cu/Fe-HAO were collected at the SER-CAT
beamline 22-ID at the Advanced Photon Source (APS), Argonne National Laboratory, Argonne, IL. All
data collection was performed at 100 K. The diffraction data was indexed, integrated and scaled with
(37). The structures were solved by molecular replacement using MOLREP program of the CCP4 suite
(56) with the HAO structure from C. metallidurans (PDB accession number 1YFU) as search model.
Electron density was fit and refined using Coot (57)and REFMAC5 (58).
4.3.8 Fluorescence spectroscopy.
The intrinsic tryptophan fluorescence of apo-HAO (40 µM) was examined at room temperature
by using Cary Eclipse fluorescence spectrophotometer from Agilent Technologies. The buffer in use was
20 mM Tris-HCl at pH 7.6. The detection parameters were: excitation wavelength at 290 nm; slit width:
5 nm; emission monitoring range: 300 – 400 nm. The maxima of each of the measurements were
plotted against the concentration of metal ions added and fit to equation 1:
∆= ܨ

∆ܨ௫
൬ሺܭௗ + ሾܯሿ + ሾܧሿሻ − ඥሺܭௗ + ሾܯሿ + ሾܧሿሻଶ − 4ሾܯሿሾܧሿ൰
2ሾܧሿ

where [M] represents the metal concentration and [E] refers to the concentration of enzyme.
The fluorescence change (ΔF) is proportional to the fraction of enzyme bound with metal.
4.4 Result
4.4.1 Metal-ion reconstitution of HAO and activity assay.
Using holo-HAO loaded with two molar equivalents of Fe2+ per protomer as the activity
benchmark, we tested the catalytic activity of HAO reconstituted with varied orders and amounts of iron
and copper. Table 4.1 shows that when apo-HAO was reconstituted with one molar equivalent of Fe2+
per protomer, the resulting singly-loaded Fe2+-HAO exhibited greater than 80% relative activity.
However, when apo-HAO was reconstituted with one equivalent of Cu2+, only nominal activity (ca. 2%)
was detected. This trace activity is similar to that of the apo-HAO and is likely due either to incomplete
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removal of iron during protein preparation or the presence of trace metals in the reaction solution. It
appears then, that copper is unable to mediate the electron transfer between 3-HAA and O2. Addition of
copper ion, from one molar equiv up to ten equiv, to the singly loaded Fe2+-HAO caused no appreciable
change in its catalytic activity, suggesting that copper is unable to compete out iron from the active site.
Similarly, addition of excess amount of Fe2+ cannot compete out Cu2+ from the active site. These results
suggest that the enzyme active site appears to have a higher metal-binding affinity than the surface
(Cys)4 site, so the first metal ion presented binds to the (His)2Glu site rather than the (Cys)4 site.

Table 4.1 Catalytic activity of metal-reconstituted HAO

*Activity assay was performed after removing excessive metal ions following the reconstitution reaction
according to the procedure described in the Materials and Methods.
4.4.2 Spectroscopic characterization of the reconstituted HAO
Due to spin coupling between free Cu2+ ions in solution, the EPR signal intensity of the aqueous
Cu2+ is quite low. Binding to protein ligands, however, increases the EPR signal intensity so that it is
proportional to the amount of the chelated copper ions. Chelation also alters the EPR signal lineshape,
which is sensitive to the ligand set and protein environment. Reconstitution of apo-HAO with a
stoichiometric amount of Cu2+ gave rise to an EPR signal indicative of a type II Cu2+ center coordinated by
a mixture of N/O ligands (Figure 4.2). Spin quantitation against a sample of Cu-EDTA recorded under the
same conditions suggested ca. 0.8 molar equivalent of Cu2+ per protomer. Addition of Fe2+ ion to the
copper-reconstituted HAO did not reduce the intensity of the EPR signal, as expected based on the data
presented in Table 1. The Cu2+ EPR signal was nearly absent from the samples in which Cu2+ was added
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to the singly loaded Fe2+ ion, also consistent with the activity assays. Moreover, this result suggests that

Figure 4.2 X-band EPR spectrum of Cu-reconstituted HAO measured at 20 K with 0.02 mW
microwave power.
Cu2+ is unable to bind to the (Cys)4 site.
4.4.3 Mössbauer spectroscopy
Mössbauer spectroscopy was utilized to characterize the Fe2+ ions of the various reconstituted
proteins. Under anaerobic conditions, apo-HAO was reconstituted with 57Fe2+ and/or Cu2+, one
equivalent at a time. This procedure generated a series of samples which contained 57Fe/57Fe, 57Fe/Cu,
and Cu/57Fe reconstituted in the specified orders, respectively. The Mössbauer spectrum of the
57

Fe/57Fe-reconstituted HAO sample taken at 77 K, shown in Figure 4.3A, consists of two distinct sets of

quadrupole doublets with roughly equal signal intensities. Spectral simulation shows that one
quadrupole doublet displays an isomer shift (δ) value of 1.37 mm/s and quadrupole splitting (ΔEQ) value
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of 2.95 mm/s. These values are consistent with N/O mixed ligation for a high-spin (S = 2) Fe2+ center and
are comparable to the values reported for the protocatechuate 4,5-dioxygenase (59). This quadrupole
doublet is therefore assigned to the Fe(His)2Glu center. The second quadrupole doublet shows a δ value
of 0.52 and a ΔEQ value of 0.57, which is characteristic of a ferrous rubredoxin-like Fe(Cys)4 center at the
S = 2 state (60-62). Thus, it is assigned to the Fe(Cys)4 center.

Figure 4.3 Mössbauer spectra of HAO
reconstituted with (A) 2Fe (B) 1Cu + 1Fe
(C) 1Fe + 1Cu (data: black; simulation of
doublet 1: red; simulation of doublet 2:
green.

Figure 4.3B shows the Mössbauer spectrum of Cu/Fe-reconstituted HAO. Both of the
quadrupole doublets seen in the 57Fe/57Fe-reconstituted HAO sample are present though not at equal
intensities. Most of the 57Fe signal arises from the ruberdoxin-like Fe(Cys)4 center, while the catalytic
Fe(His)2Glu center only accounts for 18% of the total iron. Conversely, when iron is loaded before
copper (57Fe/Cu-reconstituted HAO), the majority of the 57Fe signal is seen from the catalytic center
(75%) (Figure 4.3C). These data further support the notion that the catalytic center has priority for metal
ion binding. The observation that the order of metal loading is able to significantly alter the distribution
of the metals between the two metal-binding sites but that neither metal is able to completely occupy
either site suggests that the metal binding affinity of the two sites are similar though differentiable.
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4.4.4 Metal binding affinity measured by tryptophan intrinsic fluorescence study.
The intrinsic tryptophan fluorescence of HAO allows for the use of fluorescence spectroscopy to monitor
the binding of metal ions to the enzyme. The tryptophan fluorescence signal of apo-HAO is quenched
upon addition of either Fe2+ or Cu2+ (Figure 4.4). Notably, copper and iron show different quenching
behavior on the fluorescence signal. Titration of Fe2+ to apo-HAO causes the fluorescent signal to redshift by 23 nm from 335 nm, and the intensity to decrease to ~15% of its initial value. These effects are
seen to saturate at 2 – 2.5 equivalents of Fe2+. In contrast, when Cu2+ was used, the fluorescence signal
red-shifts by 5 nm from 335 nm concomitant with a reduction in intensity to ~ 60% of its initial value.
Also distinct from iron, the effects caused by copper saturates at about 1 equivalent, rather than 2.
These results indicate that apo-HAO can bind two Fe2+ but only one Cu2+. Furthermore, the Kd values of
iron were determined to be 5 and 12 µM for the catalytic and rebrudoxin sites, respectively.

Figure 4.4 Intrinsic fluorescence spectrum of apo-HAO (black trace) quenched by titration of
Fe2+ ion at 0.25 molar equivalent of increments

4.4.5 Crystal structures of Cu/Fe-HAO and Fe/Cu-HAO
We obtained single crystals of Cu/Fe- and Fe/Cu-reconstituted HAO proteins and determined
their structures by X-ray crystallography (Figure 4.5). These crystals belong to the P6522 space group.
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One protomer has been observed in each asymmetric unit, however each protomer forms a dimer with
a neighboring protomer in an adjacent asymmetric unit as previously observed (11). Size-exclusion
chromatography shows that HAO is eluted as a dimer of 38 kDa, which supports that the native
quaternary structure of HAO is dimeric. The Cu/Fe-HAO crystal structure was determined at 1.75 Å
(Figure 4.5B), which allows for detailed comparisons of the metal centers between this structure and the
previously-solved holo-HAO (i.e., Fe/Fe-HAO) structure from the same species (Figure 4.5A) (54). The
overall structures of Cu/Fe-HAO and Fe/Fe-HAO are nearly identical. The Cu/Fe-HAO clearly contains

Figure 4.5 The metal sites in HAO reconstituted with different metals. (A) Ribbon diagram of holoHAD with zoom-in view on the active site and the Fe(Cys)4 site (purple, PDB entry 1YFU); (B) Ribbon
diagram of Cu/Fe-HAO with zoom-in view on the active site and the Fe(Cys)4 site (yellow, PDB entry
4HVO); (C) Ribbon diagram of Fe/Cu-HAO with zoom-in view on the active site (green, PDB entry
4HVQ);The metal ions are represented in larger spheres while water molecules are shown in smaller
scale spheres with respective colors. 2Fo–Fc electron density map is countered to 1σ. This ﬁgure was
produced using PyMol.
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two metal centers. In the catalytic center, the metal ion is coordinated by His51 and His95 with the bond
distances of 2.0 and 1.9 Å, respectively. The bidentate ligand Glu57 in the Fe/Fe-HAO structure is no
longer a metal ligand in the Cu/Fe-HAO structure, although it is still close to the copper ion with Oε1 and
Oε2 at 3.1 and 3.2 Å, respectively. This metal ion is assigned to copper based on the coordination
difference to the Fe/Fe-HAO structure and is consistent with the activity assays and spectroscopic
characterizations. Furthermore, three water ligands, at distances of 2.3, 2.8, and 2.9 Å to the active-site
metal center, respectively, are observed in Cu/Fe-HAO rather than two at 2.8 and 2.8 Å as is seen in
Fe/Fe-HAO. The other metal center shows identical structure to what was reported for the Fe(Cys)4
center in the Fe/Fe-HAO structure.
The Fe/Cu-reconstituted HAO proved difficult to crystallize, and the crystals obtained were very
fragile and tended to break when immersed into the cryoprotectant. The best structure obtained was
only able to be refined to 2.80 Å resolution (Figure 4.5C). The metal coordination at the catalytic center
closely resembles that of Fe/Fe-HAO. The bond distances are 2.0, 2.2, 2.8, and 2.4 Å for Nδ of His51, Nε
of His95, and the two oxygen atoms in the carboxyl moiety of Glu57, respectively. It is noteworthy that
the structure of Fe/Cu-HAO lacks the surface metal center at the rubredoxin site. Moreover, comparison
of this region with that of Fe/Fe-HAO reveals that the electron density of amino acids 154-174 (11.5% of

Figure 4.6 Stability of FeCu- and CuFe-HAO. (A) Structure of the 89 – 174 residues in holoHAD; (B) Structure of the 89 – 154 residues in FeCu-HAD. The collapse containing residue 155
– 174 observed in comparsion of holo- and FeCu-HAD. The B-factor plots of CuFe-HAO and
FeCu-HAO are shown in (C) and (D), respectively.
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the total sequence) is missing, presumably due to increased conformational flexibility (Figure 4.6A and
4.6B). Figure 4.6C and 4.6D present the structures of Cu/Fe-HAO and Fe/Cu-HAO by their respective Bfactors. The result shows a conformation flexibility at the (Cys)4 site when the iron ion is absent.
Notably, the disorder at the rebredoxin-like site has no observable effect on the N-terminal domain
where the catalytic iron center is located. Therefore the conformation flexibility at the second Fe site
should have no observable impact to catalysis. These results are consistent with the above mentioned
spectroscopic conclusions that the first metal introduced to apo-HAO binds to the active site, and
further reveal that the (Cys)4 site is selective for iron rather than copper.
4.4.6 The Fe(Cys)4 is capable of delivering its Fe ion to apo-HAO
The DALI search (30) carried out in a previous study showed that fourteen cupin proteins
structurally resemble HAO (14). Although the overall structures display similarities to HAO, none of the
identified proteins possess an Fe(Cys)4 site. Therefore, we performed a structural search of partial
prokaryotic HAO structures with special attention to the rubredoxin-like domain that contains the
Fe(Cys)4 center. The protein most structurally similar to the rubredoxin-like domain of HAO found from a
DALI search is Kti11P (PDB entry 1YOP). Kti11P is a known iron chaperon protein with an Fe(Cys)4

Figure 4.7 Comparison of structures of Kti11p (left) and holo-HAD (right). The spheres
represent the metal ions.
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center. The structures of the rubredoxin-like domain of both Kti11P and HAO contain a β-sandwich as
well as an α-helix (Figure 4.7). Notably, the Fe(Cys)4 is observed in prokaryotic HAO while Zn(Cys)4 is
shown in Kti11P. Unfortunately, zinc-reconstitution caused protein denaturation in HAO. Earlier studies
suggested that Kti11P is a zinc-finger-like protein with multiple functions, including chaperoning iron and
assisting the translocation of a membrane protein (31, 32). However, more recent studies revealed that
Kti11P and many of the proteins possessing the zinc-finger-like structures have higher affinity to Fe ions
and their primary role is to shuttle iron (33). Another example which has the aforementioned feature is
Dph4, whose role as Fe-chaperon has recently been demonstrated (33). The similarity of the second
metal binding site of HAO to these Fe chaperon proteins suggest that the Fe(Cys)4 center of HAO may
serve as an endogenous Fe-chaperon.
In order to test this hypothesis, we premixed apo-HAO and holo-HAO at different ratios with the
final concentration of holo-HAO kept constant and measured the activity of the enzyme mixtures after
incubation. Figure 4.8 shows that the presence of apo-HAO increased the specific activity compared to
the control experiment which contained only holo-HAO. The increase in specific activity was dependent
on apo-HAO concentration, and the activity reached a plateau at double the activity of holo-HAO up
addition of ~4 equivalents of apo-HAO. These results suggest that the iron at the Fe(Cys)4 cite of holo-

Figure 4.8 Addition of apo-HAO to holo-HAO can increase the catalytic activity. The inset
shows representative kinetic traces.
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HAO can be transferred to the active site of apo-HAO, increasing the population of catalytically active
protein molecules. Myoglobin and tryptophan, 2-3-dioxygenase, which each contain a type-b heme,
were used in place of holo-HAO as negative controls. Neither heme protein was able to transfer its iron
ion to apo-HAO.
4.4 Discussion
Rubredoxin-like Fe(Cys)4 centers are prevalent in nature. The primary role of this metal center is
typically to mediate electron transfer (63-66), although there are isolated reports which found
alternative functions such as catalysis (67), and oxidative stress protection (68). In this work, a new
function for this canonical iron center as endogenous iron-chaperon is suggested.
The salient feature of HAO from Saccharomyces cerevisiae and prokaryotic sources is the
presence of an Fe(Cys)4 center not found in eukaryotic enzymes. The Fe(His)2Glu center is the catalytic
center and is fully competent for activating dioxygen and mediating electron transfer from the substrate
to dioxygen. The observation of a second iron site which is not involved in catalysis is then quite
intriguing. Our combined kinetic assays, crystallographic studies, and EPR and Mössbauer spectroscopic
characterizations show that (1) the active site has a higher binding affinity than the rubredoxin-like site
for metal ions, (2) the structure and properties of the catalytic center are independent of the
rubredoxin-like site, and (3) the (Cys)4 center binds Fe but not copper, and the Fe ion bound there can
function as a spare tire to ensure the availability of iron to the catalytic center in addition to playing a
structural role in stabilizing the rubredoxin-like domain. The Kd values determined from intrinsic
fluorescence further help to elucidate the feasibility of iron transfer between the two metal binding
sites. A similar metal competing and conservation mechanism may exist in other proteins which play
vital roles in essential metabolic pathways.
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Prior to this work, it was not known why bacterial HAOs possess a second iron binding site
similar to the metal centers of rubredoxin and several zinc-finger proteins which contain rubredoxin-like
knuckles. Previous studies have shown that zinc ions inhibit the catalytic activity of HAO and suggests
that the (Cys)4 site is not designed for zinc binding in vivo (53, 69). The rubredoxin-type Fe(Cys)4
mononuclear iron center is the simplest iron-sulfur center with tetrahedral coordination of the iron ion.
Cys residues form common loop structure known as a ‘‘knuckle’’ (Cys-X-X-Cys-X-X) (36). Any mutation on
the Fe(Cys)4 center of HAO in previous (54) and current studies results in insoluble proteins. Several
representative proteins like Dph4 and HscB in the J-protein family, as well as frataxin, contain the
aforementioned structural features (33, 37). These proteins have previously been identified as putative
iron donors in mitochontrial iron-sulfur cluster assembly. Iron is stored in the Fe(Cys)4 cluster of these
proteins and delivered to their partner proteins during the biosynthesis of the iron-sulfur clusters. The
structural similarity of the Fe(Cys)4 center of HAO to the iron donor proteins and its slightly lower affinity
for iron binding compared to the active site metal center led us to propose a new role for it. The
biochemical and structural results collectively point the reburedoxin-like iron center as an iron storage
and chaperone role to ensure the catalytic site is loaded, i.e., it serves as an endogenous iron chaperon
to provide iron to the active site if the active site iron ion is lost.
This spare Fe center may become important in bacteria living on nitrobenzoic acid as their sole
source of carbon, nitrogen, and energy. The non-heme Fe ion at the active site is easily lost during
protein purification, and this may occur in cells because many of the metabolic intermediates in the 2NBA degradation pathway are capable of chelating metal ions. For bacteria which use 2-NBA as their
sole carbon/nitrogen/energy source, HAO is a critical enzyme which must always be active. In contrast,
the iron storage strategy does not necessarily exist in eukaryotic HAO, because the kynurenine pathway
is not as vital for survival of the organism.
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5. PIRIN IS An IRON-DEPENDENT REDOX REGULATOR OF NF-κB

5.1 Abstract
Pirin is a nuclear non-heme Fe protein of unknown function present in all human tissues. Here
we describe that pirin may act as a redox sensor for the NF-κB transcription factor, a critical mediator of
intracellular signaling that has been linked to cellular responses to pro-inflammatory signals and which
controls the expression of a vast array of genes involved in immune and stress responses. Pirin’s
regulatory effect was tested with several metals and at different oxidations states, and our
spectroscopic results show that only the ferric form of pirin substantially facilities binding of NF-κB
proteins to target κB genes, a finding which suggests that pirin performs a redox sensing role in NF-κB
regulation. The molecular mechanism of such a metal identity- and redox state-dependent regulation is
revealed by our structural studies of pirin. The ferrous and ferric pirin proteins differ only by one
electron, yet they have distinct conformations. The Fe center is shown to play an allosteric role on an Rshaped surface area that has two distinct conformations based on the identity and the formal redox
state of the metal. We show that the R-shaped area comprises the interface for pirin-NF-κB binding
which is responsible for modulation of NF-κB’s DNA binding properties. The non-heme Fe protein pirin is
proposed to serve as a reversible functional switch that enables NF-κB to respond to changes in the
redox levels of the cell nucleus.
5.2 Introduction
The transcription factor, nuclear factor κB (NF-κB), discovered in 1986 (70, 71), is a ubiquitous
cellular regulator widely recognized as a critical mediator of intracellular signaling for
immune/inflammatory response including oxidative stress (72-74). NF-κB is a family of structurally
related and functionally conserved dimeric proteins which consist of RelA (p65), RelB, c-Rel, p50, and
p52. All members can form both homo and heterodimers with different physiological functions and gene
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targets (75-77). NF-κB proteins bind and activate several hundred κB genes in response to activating
stimuli (78-80). The activity of NF-κB is tightly controlled by regulatory proteins and cofactors
collectively known as co-regulators (81, 82). Complex regulatory networks exist to ensure that NF-κB is
only activated by appropriate stimuli and is then inactivated when no longer needed (83-85). NF-κB
typically resides in the cytoplasm in an apparently inhibited state bound with an inhibitory protein
known as IκBα. Previous studies have established that NF-κB activation is first achieved by
phosphorylation of the inhibitory protein IκBα to liberate NF-κB to their free forms. Next, NF-κB
proteins are translocated to the nucleus where, with the help of co-regulators, they will orchestrate the
cascade of signaling responses to the external stimuli. At present, the precise roles played by the coregulators in the cell nucleus are poorly understood.
Winnacker and coworkers in 1997 identified a highly conserved human protein by using nuclear
factor I as a “bait protein” and named it pirin (86). This previously unknown protein is expressed in all
human tissues. Biochemical data suggests that pirin is a nuclear protein comprised of 290 amino acids,
ca. 32 kDa (86). Experiments using genomic Southern and Western blots have demonstrated the
presence of pirin genes and their expression in dot-like sub-nuclear structures that represent loci of
specific nuclear processes including DNA replication and/or RNA polymerase II transcription (86). Pirin
has been found to form tight complexes with the inducible anti-apoptotic transcription factor NF-κB p50
homodimer and the proto-oncoprotein Bcl-3 (87). In a gel mobility shift assay using cell lysates, pirin
was shown to enhance the DNA binding activity of the p50-Bcl-3 complex (87). These observations led
to the initial suggestion that pirin functions as a co-regulator in the NF-κB transcription complex (87).
However, such a proposed regulation has not been confirmed and the mechanism of which is
completely unknown.
In the subsequent studies by various laboratories, pirin is found to be a non-heme iron-binding
protein that belongs to an ancient redox-sensitive subclass of proteins in the cupin superfamily (12, 88,

59
89). Pirin has additionally been linked experimentally to the metastasis of melanoma cells (90, 91). A
knockdown experiment in melanoma cells has confirmed that pirin interacts with Bcl-3 and is associated
with cell migration (91). It has been shown that pirin expression is significantly up-regulated in the
spleen and kidney of cytosolic superoxide dismutase (SOD)-deficient mice (92). Similarly, up-regulation
of pirin expression by chronic cigarette smoking has been associated with bronchial epithelial cell
apoptosis (93). The crystal structure of pirin at 2.1 Å resolution reveals a ferrous site that is octahedrally
coordinated with three histidines, one glutamate, and two water molecules (12). In the present work,
we describe that pirin substantially facilitates the DNA binding of NF-κB p65 to the IgκB gene when the
metal center is a ferric ion. An unprecedented redox regulation mechanism is proposed from the
previous studies and the results described below.
5.3 Materials and Methods
5.3.1 Protein materials
The full-length (1 - 290 amino acids) untagged form of human Pirin was cloned and expressed in
Escherichia coli strain BL21(DE3) (Invitrogen). Cells were grown at 37°C in LB media with 50 μg/ml
kanamycin until an OD600 around 0.6 - 0.8 was achieved. Protein expression was induced by 0.4 mM
isopropyl-β-D-thiogalactopyranoside. Cells were further grown for 16 hours at 28°C before harvesting by
centrifugation at 8000 × g for 15 min. The cells were re-suspended in the lysis buffer (15 ml per gram cell
pellet), which consisted of 20 mM HEPES (pH 7.5), 150 mM NaCl, 2 mM EDTA, 0.2 mM
phenylmethylsulfonyl fluoride and 10 mM β-mercaptoethanol, 5% glycerol. The cell membrane was
broken by an automated cell disruptor made by Microfluidics (M-110P) to release proteins. The
purification of pirin protein consisted ammonium sulfate fractionation and three major chromatographic
steps including SP Sepharose, Superdex 75, and MonoS on an ÅKTA FPLC system (GE Healthcare). The
metal-free apo-protein of pirn was isolated from iron-depleted minimum medium and metal
reconstitution details are given in the on-line methods. The His6-tagged truncated versions of human
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p65 (19-291) was used in the previous studies (94, 95) by Dr. Gourisankar Ghosh of University of
California San Diego and the plasmid was obtained from Dr. Jim Maher, III of Mayo Clinic College of
Medicine. The metal-free protein was isolated from an iron-depleted minimal medium (96). The purified
protein was treated with 10 equivalents of EDTA overnight and then desalted with 20 mM Tris-HCl
buffer (pH 7.4) containing 50 mM NaCl and 5% glycerol.
5.3.2 Metal analysis
Metal contents of each pirin sample were determined by inductively coupled plasma optical
emission spectrometry using a Spectro Genesis spectrometer (Spectro Analytical Instruments GmbH &
Co. KG, Germany). Calibration curves were obtained by measuring the standards at the concentrations
of each element at 0, 0.1, 0.3, 0.5, 1.0 and 10 ppm (mg/L).
5.3.3 Nuclear extract containing native NF-κB proteins
Nuclear extract of HeLa cells was prepared by using Subcellular Protein Fractionation Kit for
Cultured Cells from Pierce Protein Research Products (Thermo Fisher Scientific) according to the
manufacturer’s protocols. Prior to injection, the extract was diluted to 0.08 µg/mL by the SPR binding
buffer described above. The binding measurements were taken with the extract alone and together with
added pirin (10 µM) protein.
5.3.4 DNA
The κB-site DNA used was synthetic oligonucleotide 5’-biotin-GAGTTGAGGGGACTTTCCCAGGC-3’
(κB site is shown in bold). The single strand DNA was annealed to its complementary strand before use.
A non-specific DNA sequence of 5’-CCTATATGCGGCGTATATCC-3’ (a generous gift from Dr. W. David
Wilson) was used as a negative control
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5.3.5 Spectroscopy
SPR measurements were carried out on a Biacore T200 instrument (GE Healthcare). Biotinylated
double-stranded IgκB DNA was immobilized to streptavidin-coated sensor chips using standard
procedures. The protein-DNA binding was carried out at 20 °C in 20 mM Tris-HCl, (pH 7.4), containing 50
mM NaCl and 0.005% surfactant P20 at a 50 µl/min flow rate. The effect of pirin upon NF-κB binding the
IgκB sequence was studied by flowing the protein over the sensor chip and comparing the levels of DNA
binding in the absence and presence of the putative co-regulator protein. The final concentration of p65
was 50 nM in the SPR injection buffer while pirin concentration was varied from 0 - 25 µM. After
injecting protein samples for 420 seconds, buffer was injected from 420 - 1220 s to rinse the weakly
bound proteins from the chip surface in order to monitor the dissociation of the protein or protein
complexes. Vitamin C was injected at 980 s in the reversibility testing experiments. The sensor chip
surface was regenerated with 0.1% SDS and 3 mM EDTA between each measurement. The anaerobic
SPR experiments were performed using O2-free, argon-saturated buffer.
QCM-D measurements were performed on an E4 instrument (Q-Sense, Sweden) with biotinfunctionalized sensors. Streptavidin was flowed over the biotinylated surface, followed by biotin-labeled
IgκB-site DNA for immobilization. The equilibrium buffer was 20 mM Tris-HCl (pH 7.4) containing 50 mM
NaCl. In each measurement, a total volume of 500 µl was continuously injected at a flow rate of 150
µl/min followed by buffer injection for an additional 300 seconds. The net change in frequency and
dissipation was calculated by subtracting the values recorded at the sample injection time from those
recorded at the end of each rinsing step. This eliminated the influence of nonspecific, loosely bound
proteins on the DNA-immobilized surface. The surface was regenerated between each sample injection
by flowing through 0.05% SDS followed by the equilibrium buffer until the baseline was restored. The
concentration of p65 was maintained at 0.5 µM, while pirin concentration varied from 0, 0.5, 1.5, 2.5
and 5 µM for each run of the sample application.
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Fluorescence spectroscopy was performed on a Cary Eclipse fluorescence spectrophotometer from
Agilent technologies Inc., CA. Purified p65 was titrated into the fluorescence cuvette containing FAMlabeled double-stranded DNA with IgκB sequence in the presence or absence of Fe(III)-pirin, or pirin
reconstituted with other metal ions in 20 mM Tris-HCl buffer (pH 7.4) and 50 mM NaCl.
The midpoint redox potential of pirin was determined by using a single-wall carbon nanotubemodified electrode in a spectroelectrochemical cell hosted in a N2-filled, O2-free plastic bag. Pirin (500
µM) in 50 mM Tris-HCl (pH 7.4) was used in this study. The formal potential was obtained from the
recorded cyclic voltammetry curves.
X-band EPR spectra were obtained in perpendicular mode on a Bruker E200 spectrometer at
100-kHz modulation frequency using a high sensitivity resonator ER4119HS at 10 K maintained by an
ESR910 liquid helium cryostat and an Oxford ITC503S temperature controller). Measurements were
conducted by maintaining the frequency of the electromagnetic radiation constant while the magnetic
field was swept. Pirin (160 µL/sample, 200 – 450 µM) was prepared in a quartz EPR tube with 20 mM
Tris-HCl buffer (pH 7.4) containing 50 mM NaCl.
5.3.6 Crystallizations and X-ray structure determinations
Pirin was crystallized through optimization of the conditions previously established(12) by
hanging drop vapor diffusion in VDX plates (Hampton Research). Single crystals suitable for X-ray data
collection were obtained from drops assembled with 1 μL protein solution layered with 1 μL reservoir
solution containing 0.1 M MOPS pH (6.5), 15% PEG 20000. Crystal growth took place in a vibration-free
crystal growth refrigerator from Molecular Dimensions at 16 °C. The crystals were mounted in small
loops of fine rayon fiber and flash-cooled directly in liquid nitrogen after being dipped into the
cryoprotectant solution that contained 0.1 M MOPS pH (6.5), 17% PEG 20000 and 30% ethylene glycol.
Initial screening was carried out using a Rigaku MicroMax 007 HF Cu-rotating anode X-ray generator,
operated at 40 V and 30 mA, and utilizing a Saturn 944 CCD area detector at Emory University. X-ray
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diffraction data of Fe(III)-, putative Fe(II)-bound peroxo pirin, Mn(III)-, and Co(II)-pirin were collected by
the Rigaku X-ray facility. X-ray diffraction data of Mn(II)-pirin was collected at the SER-CAT beamline 22ID at the Advanced Photon Source (APS), Argonne National Laboratory, Argonne, IL. All data collection
was performed at 100 K. The diffraction data were indexed, integrated and scaled with HKL2000 (37).
The structures were solved by molecular replacement using MOLREP program (56) of the CCP4 suite (39)
with Fe(II)-pirin structure (PDB accession number 1J1L) (12) as search model. Electron density was fit
and refined using Coot (40), REFMAC (42) and PHASER (97). Figures showing crystal structures were
drawn with PyMOL (http://ww.pymol.org).
5.3.7 In silico docking of the supercomplex
The docking model of pirin with p65 and κB DNA was constructed by using the ZDOCK utility and
server (http://zdock.umassmed.edu) (98). The PDB files of ferric pirin (PDB accession number 4GUL) and
p65 (1RAM) (99) were used in model building. The top-ranked result shown in Figure 5 involves the Rshaped area of pirin, which has been shown in the structural study to differ in conformation when the
metal oxidation state changes or metal substitution occurs.
5.3.8 Experimental validation of the docking study
The modeling results were further tested by site-directed mutagenesis experiments. The point
mutants of pirin were generated by using the QuikChange II kit purchased from Qiagen (for details, see
Supplementary Information). The sequences of the mutants were verified by DNA sequencing prior to
expressing and purifying proteins. The procedures used for the expression, purification, metalreconstitution and oxidation of the pirin variants were the same as described previously for the wildtype protein.
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5.3.9 Accession codes
Atomic coordinates and structure factors have been deposited with the Protein Data bank
under accession codes (resolution): 4GUL (1.80 Å), 4EWA (2.47 Å), 4EWE (1.56 Å), 4ERO (2.65 Å), 4EWD
(2.15 Å), and 4HLT (1.70 Å).
5.4 Results
5.4.1 Human pirin facilitates the DNA binding of p65 to the κB gene in a redox-state dependent
manner
We studied the effect of pirin on the binding affinity of p65 (residues 19-291) (99) homodimers
to the immunoglobulin κB target sequence (IgκB) by testing isolated protein using surface plasmon
resonance (SPR) spectroscopy. The first significant observation is that Fe(III)-pirin, generated by oxidizing
Fe(II)-pirin with ferricyanide, or O2 in a relatively slower oxidation process, and verified by EPR
spectroscopy substantially enhanced p65 binding to the IgκB target site (Figure 5.1A). In the presence of
0 – 25 µM Fe(III)-pirin, the binding was a two-phase process: a fast phase in the first 60 s with kon1’ = 1.1
× 106 M-1s-1 and a slow association phase after 60 s with kon2’ = 0.02 M-1s-1. The buffer rinse only resulted
in the loss of a small amount of mass presumably due to washing away of non-specifically bound
proteins observed in the slower binding phase. The binding is very tight, virtually no dissociation after
removing non-specifically bound proteins. This is the first experimental evidence of pirin interacting with
p65 and dramatically enhancing the binding affinity for p65 to the κB site. In contrast, Fe(II)-pirin does
not affect p65 binding to the IgκB site. The dose response with the truncated p65 is shown in Figure
5.1B. The sequence specificity of pirin’s effect on p65 has been tested by performing the same SPR
experiment using a non-specific DNA sequence. Not surprisingly, the pirin-p65 complex did not interact
with the non-specific DNA sequence regardless of the formal oxidation state of the iron ion in pirin.
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Figure 5.1 The ferric, not ferrous, form of pirin substantially facilities binding of p65 to IgκB
gene in SPR spectroscopy. (A) Detection of apo-, Fe(II)-, and Fe(III)-pirin effect on p65 binding to
the IgκB site, (B) the response unit as a function of the pirin (1-290):p65 (19-291) ratio, (C) SPR
spectroscopy with Fe(III)- and metal-substituted pirin proteins, (D) The effect of exogenous pirin
to native NF-κB of the nuclear extract of HeLa cells, (E) QCM-D spectroscopy of p65 alone (red
trace) and along with Fe(III)-pirin in (1:1 to 1:10 ratio as indicated by 1x, 3x, 5x, and 10x), and (F)
comparison of the ΔD/Δf slope in a QCM-D study that indicates a conformational difference of
the protein-DNA complex. The SPR traces are color-coded with p65 only (red), p65 with Fe(II)pirin (black), Fe(III)-pirin (blue), metal-striped pirin (purple), Co(II)-pirin (pink), Mn(II)-pirin (dark
yellow), Mn(III)-pirin (wine), and Ni(II)-pirin (olive). Fe(III)-pirin alone (cyan) is shown in (A) and
HeLa nuclear extract only (navy) is shown in (D) as controls, respectively.
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To determine whether other transition metal ions can function in place of the iron cofactor,
apo-pirin was prepared from Fe-depleted minimal medium and charged with divalent metal ions. Co-,
Mn-, and Ni-reconstituted proteins were stable and contained about 0.6 metal ions per molecule of pirin
as determined by ICP-OES analysis (Table 5.1). These metal-substituted pirin proteins had minimal
effects on p65 and were unable to achieve the effect observed for NF-κB with ferric pirin (Figure 5.1C).
We wondered if a metal, other than iron, with correct valence state (i.e., trivalent) would make pirin
active. We oxidized Mn(II)-pirin protein using potassium ferricyanide. After an overnight incubation, the
protein was desalted to remove the oxidant and crystallized. As the oxidation state rises, each metal
ligand increases its bond length in the Mn-substituted pirin metal center, a scenario similar to what is
observed in Fe-pirin structures. The change of the oxidation state of pirin was validated by low
temperature EPR spectroscopy measured before and after the oxidation reaction by the disappearance
of the Mn(II) EPR signal. This is the same method we used to generate Fe(III)-pirin from Fe(II)-pirin, with
the exception of a shorter incubation time (4 h) and after which the colorless Fe(II)-pirin turned into a
pale yellow colored solution and a high-spin (S = 5/2) ferric EPR signal was fully developed from the EPRsilent state. As shown in Figure 5.1C, the Co(II)-, Mn(II)-, and Mn(III)-substituted pirin proteins have little
or no activity towards NF-κB. A similar effect was also observed by fluorescence spectroscopy. When the
5’-FAM-labeled κB DNA was titrated by p65 in the absence of pirin, the 520 nm emission intensity
increased as previously reported (100). In contrast, the titration using p65 and Fe(III)-pirin induced an
increase in emission signal intensity that was nearly 4-fold larger than p65 alone, an effect not seen
when pirin is complexed with other metals such as Co(II) and Cu(II) (Figure 5.2). The change in
fluorescence intensity as a function of p65 concentration resulted in a sigmoidal curve, indicative of the
binding cooperativity previously reported in studies of NF-κB and DNA interactions (100). All the
available reducing agents affect the fluorescein in FAM and resulted in less excitation energy. Thus, the
fluorescence assays with Fe(II)-pirin cannot be performed in the current stage.
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Figure 5.2. Fluorescence spectroscopic study of pirin’s effect on p65’s binding to the IgκB gene.
The concentration of p65 is plotted as a function of the change in emission intensity originated
from the 5’-FAM fluorescent label of the IgκB DNA in the fluorescence study.

Table 5.1. Metal analysis of Pirin by inductively coupled plasma optical emission
spectrometry (ICP-OES). Values were obtained as average of three measurements with
standard errors less than 5%. The data are present as molar ratio per pirin molecule.
Human Pirin Protein

Fe

Zn

Cu

Mn

Co

Ni

As-isolated untagged
recombinant pirin

0.63

0.19

<0.01

<0.01

<0.01

<0.01

<0.10

<0.01

<0.01

<0.01

<0.01

<0.01

1.00

<0.01

<0.01

<0.01

<0.01

<0.01

Metal-free apo-pirin
Fe-reconstituted, from
apo-pirin
Co-reconstituted, from
apo-pirin

<0.01

<0.01

<0.01

<0.01

0.60
<0.01

Mn-reconstituted, from
apo-pirin

<0.01

Ni-reconstituted, from
apo-pirin

<0.01

<0.01

<0.01

0.63

<0.01
<0.01

<0.01

<0.01

<0.01

<0.01
0.61
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Pirin’s effect on NF-κB was further investigated with native NF-κB proteins in cell lines. Figure
5.1D shows the effect of isolated pirin on the nuclear extract from HeLa cells, which were not under
redox stress, i.e. the NF-κB proteins were not yet induced for activation. The freshly prepared nuclear
extract (at a total protein concentration of 0.08 µg/ml) was injected into the IgκB-coated SPR sensor
chip simultaneously with exogenous Fe(III)-pirin. The inclusion of isolated Fe(III)-pirin protein with the
nuclear extract increased binding by about 25-fold compared to the extract alone. Fe(II)-pirin and metalsubstituted pirin failed to induce the same effect.
5.4.2 The protein-DNA supercomplex in the presence of pirin is compact and rigid

We also tested if NF-κB and the DNA change their structures after forming a complex. Quartz
crystal microbalance with dissipation (QCM-D) was employed to monitor pirin’s effect on the
conformation of the p65-DNA complex (Figure 5.1E). The plot of the change in dissipation (ΔD) vs. the
shift in frequency (Δf) displays a more moderate slope when pirin is present (Figure 5.1F). A less steep
ΔD vs. Δf slope indicates a more compact, rigid layer formed upon the sensor (101). This result suggests
that the conformation of the supercomplex is altered with respect to the NF-κB and DNA mixture. This
observation is also consistent with previous studies showing that κB sequences are bent to various
degrees upon NF-κB binding (75, 102). DNA bending is a common prerequisite to the formation of a fully
active transcriptional complex (103).
5.4.3 Pirin-NF-κB-DNA supercomplex dissociates by added reducing agent
We determined the midpoint reduction potential (Em) for the ferrous/ferric couple of pirin by
cyclic voltammetry. The resulting curve shown in Figure 5.3A resembles published data on the nonheme FeB of nitric oxide reductase (104). At pH 7.4, the Em value is +80 mV vs. an Ag/AgCl electrode.
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Figure 5.3 The function of pirin on p65 is reversible depending on the redox state of the iron center.
(A) Determination of the reduction potential of pirin by film cyclic voltammetry in an anaerobic chamber.
(B) X-band EPR spectroscopy shows reversibility of the Fe(II)/Fe(III) couple in response to L-ascorbate.
Fe(II)-pirin (250 µM, trace 1) after oxidation by O2 for 30 min (or 1 equivalent of H2O2 for 1 min, trace 2),
addition of 1 mM L-ascorbate for 5 min (trace 3) and for 60 min (trace 4). (C) L-ascorbate was introduced
to the system, after forming the supercomplex from initial injection of p65/Fe(III)-pirin, at
concentrations of 0 (black), 0.25 (navy), 2.5 (magenta), and 25 mM (green) at 980 s.

70
If pirin is indeed a regulatory component in the NF-κB signaling transduction, it must be able to
dissociate after the redox levels resume to normal. We designed a continuous SPR experiment to test if
L-ascorbate would be able to dissociate the pirin•p65•IgκB supercomplex (Figure 5.3C). First, the
supercomplex was formed and the non-specifically bound proteins were washed away by buffer. At this
point, L-ascorbate was introduced to stimulate a shift in intracellular redox conditions to a less oxidative
environment. Figure 5.3C shows that L-ascorbate caused the protein supercomplex to dissociate in a
dose-dependent manner, and buffer wash without the L-ascorbate immediately halted the dissociation.
5.4.4 The redox state of the Fe in pirin affects the conformation of a specific R-shaped surface area as
revealed by X-ray protein crystallography
To further our understanding of the structural impact of pirin metal center, especially the
differences between the active Fe(III- and inactive Fe(II)-pirin and the metal-substituted pirin variants,
we determined multiple X-ray crystal structures of the active form of Fe(III)-pirin at 1.80 to 2.50 Å
resolutions (Table A3). All the pirin crystals, including we analyzed and previously published (12),
belong to the P212121 space group with one molecule per asymmetric unit.
An apparent structural change is observed when the active ferric form of pirin is aligned with
the inactive resting state of ferrous pirin. Figure 5.4A shows that the deviations are primarily located on
one face of the protein. The residues involved collectively account for ca. 20% of 290 total residues.
Notable in our structural study, a specific, R-shaped surface loop area is identified that is substantially
altered due to switching of the metal oxidation state. This area consists of residues 7–41 and 53–62
which includes the surface area surrounding the metal binding cavity at the N-terminus as well as the
interface between the two cupin domains. While the root-mean-square deviation (r.m.s.d.) of shift in
the protein backbone of this R-shaped region between the Fe(II) and Fe(III) states is modest, the
widespread
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coverage and especially the cumulative effect of the changes in the amino acid residues is extensive for
a protein of this size. Both sheet-to-coil transition and twist of orientations are observed in the R-shaped
region. Four charged residues (Arg14, Arg23, Glu32, and Lys34) in the R-shaped region show two distinct
conformations depending on the oxidation state of Fe (Figure 5.5). Arg14, for example, shifts 5.1 Å by
comparing the two structures (Figure 5.4B).

Figure 5.4 Structural comparison of ferric and ferrous pirin. (A) Structural alignment of
ferric (active towards p65) and ferrous (inactive) pirin. Colored regions indicate areas of
deviation (≥ 1 Å), while grey regions are identical. The structural differences of Fe(III)-pirin
are shown in yellow, and Fe(II)-pirin in green. (B) the zoom-in view highlights the deviation
of a special R-shaped area with distinct conformations, and (C) superimposed Fe center
structure of ferric (yellow), ferrous (green) and L-ascorbate-reduced (cyan) pirin structures.

The structural data also provide clues for the cause of the extensive conformational changes.
His56, His58, His101 and Glu103 are the coordination ligands at 2.1, 2.1, 2.3 and 2.3 Å distance from the
Fe(II) ion respectively. While the histidine residues remain coordinated to the Fe ion at 2.1, 2.1 and 2.2
Å, the negatively charged ligand, Glu103, moves away from the Fe ion in the oxidized protein (Figure
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Figure 5.5. Key residues at the “active site” of pirin in the R-shaped surface loop including—the
relative orientation and the electron densities of Arg14, Arg23, Glu32, and Lys34 in the structural
data. (a) Fe(III)-pirin (4GUL) and (b) Fe(II)-pirin (1J1L). The 2Fo-Fc electron densities are contoured
at 1.0 σ.
5.4C). The Fe-Glu103 distance lies in 2.5 - 3.2 Å in multiple ferric pirin structures determined (Figure 5.6).
This is an unexpected observation. However, the positively charged Fe ion still sits in a highly negatively
charged cavity. We noticed that Glu103 connects the R-shaped surface through a well-defined H-bond
network (Figure 5.7). It is highly possible that redox state change-induced R-shape loop deviations are
mainly triggered by the iron ion through Glu103.
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Figure 5.6 The electron density comparison of fully oxidized and reduced pirin iron centers. (a)
Fe(III)-pirin (4EWA) and (b) Fe(II)-pirin (1J1L). The 2Fo-Fc electron densities are contoured at 1.0 σ.
Note that the exact number and the chemical nature (i.e., water or hydroxide) of the solventderived ligands cannot be definitely determined by X-ray protein crystallography at these
resolutions and they may be affected by X-ray resource during data collections.

5.4.5 The crystal structures of the intermediate states of Fe-Pirin show the reversibility of the R-shaped
loop conformation changes dependent on the oxidation state of the metal
We have trapped the intermediate states of Pirin in response to changes in the redox
environment (Figure 5.8). The crystals from Fe(II)-Pirin protein grown in an anaerobic chamber, but
frozen with aerobic cryoprotectant, gave rise to an intermediate state of Pirin structure which is
different from either the ferrous- or ferric-Pirin structures. A diatomic molecule (Fig. 5.9A), assigned as
oxygen, occupies the Fe site opposite three His ligand residues. No diatomic molecule that can bind to
Fe(II) other than O2 is present in the crystallization or cryoprotectant medium. Attempts to fit the
electron density with only a single atom or with two solvents were unsuccessful and resulted in excess
residual electron density. Thus, this is a putative O2-bound state of Pirin. The bound dioxygen is ligated
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to the Fe(II) ion in a distorted side-on fashion (Fig. 5.9B), as previously seen in the non-heme Fe
dioxygenases (107, 108). The O-O bound distance, upon crystallization refinement, converged to 1.35 Å.
However, the low resolution of 2.5 Å does not definitively describe the state of the bound dioxygen
species. Nevertheless, Glu103 is no longer a metal ligand (3.00 Å) as seen in the ferrous structure, but
rather it is similar to what is observed in the ferric state (3.20 Å). The bound O2 molecule is stabilized by
Glu103 and Gln115, while Phe53 and Trp117 provide hydrophobic shielding. As described above,
soaking Fe(III)-Pirin crystals with vitamin C resulted in the structure being nearly identical to the Fe(II)Pirin structure, collectively demonstrating the reversibility of the specific structural confirmation in
respond to the change of Pirin’s redox state.
Differences in surface loops are also observed. The peroxy state of Pirin is more closely aligned

Figure 5.7 The Fe center is connected to the pirin “active site” residues (including Arg14, Arg23,
Glu32, and Lys34) through a H-bond network. The metal ligand Glu103 is proposed to trigger
conformation changes of the surface residues.
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with the Fe(III) structure than Fe(II)’s, although it is not identical to either (Fig. 5.8). The conformal
changes again are in agreement with the trend of the reversible conformational changes in the R-shaped
region highlighted in color in Fig. 5.4A. Moreover, the structural characterization of the Fe(II)-bound
peroxo species has profound implications to our understanding of how the non-heme Fe center in Pirin
interacts with molecular oxygen. This observation opens an alternate avenue for Pirin to function as an
O2 sensor for NF-κB, which reversibly binds O2, and thus not necessarily becomes oxidized to the ferric
state. At present, it is not feasible to perform SPR-based assays with the crystallized intermediate state
of Pirin.

Figure 5.8 Structural alignments of (a) Fe(III)-pirin before and after L-ascorbate soaking, and (b)
comparison of the in crystallo reduced structure with the fully Fe(II)-pirin structure. The well-aligned
parts are shown in grey and differences in color with Fe(III)-pirin structure shown in yellow, Lascorbate-reduced Fe(II)- and Fe(II)-pirin shown in cyan and green, respectively.PDB entries: Fe(II)pirin, 1J1L; Fe(III)-pirin, 4GUL; and L-ascorbate-reduced pirin, 4FHS.
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5.4.6 The metal identity affects the conformation of the R-shaped surface area
In order to understand the structural basis for the functional incapability of metal-substituted
pirin proteins, we solved the X-ray crystal structures of Co- and Mn-substituted pirin. A similar R-shaped
conformational difference is observed when comparing the active form of ferric pirin with functionally
inactive pirin variants charged with Co(II) and Mn(II) (Figure 5.10). The changes in the R-shaped region

Figure 5.9 An Fe(II)-bound peroxo intermediate state of human pirin, which is structurally similar to
Fe(III)-Pirin but distinct from the Fe(II) state of Pirin. (A) Electron density map of the Fe(II)-O2
complex. The 2Fo-Fc electron densities are countered at 1.0 σ. (B) The O2 molecule is bound to the
Fe(II) at a distorted side-on fashion, which is stabilized by Glu103 and Gln115, and is shielded by
Phe53 and Trp117. The Glu103 reside is no longer a metal ligand in the peroxy state of Pirin. (C)
Alignment of the Fe(II)-Pirin (green) versus Fe(II)-O2 (purple), and (D) Fe(III)-Pirin (yellow) versus Fe(II)O2 Pirin. Colored regions indicate areas of deviation, while grey regions are identical.
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are different from one transition metal to the next, but the location and direction of the conformation
changes show the same general trend. In order to understand why oxidized Mn-pirin is not active, which
has an oxidation state of +3, we determined its crystal structure (Figures 5.10 and 5.11). The structure of
Mn(III)-pirin (at 2.15 Å resolution) indeed differs from Fe(III)-pirin, but the conformation differences are
not the same as Mn(II)-pirin (1.56 Å resolution).

Figure 5.10 Structural alignments of Co(II)- (magenta, 4ERO), Mn(II)- (red, 4EWE), and Mn(III)- (purple,
4EWD) against Fe(III)-pirin (yellow, 4EWA). The metal center electron density maps are shown at the
right column. The well-aligned parts are shown in grey and differences in color.
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5.4.7 The R-shaped region on pirin interacts with the C-terminal domain of NF-κB proteins
The structural data led us to hypothesize that the R-shaped region is the key protein surface in pirin that
directly interacts with p65. A docking model study was subsequently conducted using ZDOCK (98) to
further investigate how pirin makes contacts with p65 (99). The result suggests that the R-shaped
surface region is the pirin·p65 interface. The R-shaped region forms much of the central binding surface
between the two proteins (Figure 5.12). The binding takes place at the C-terminal Rel homology domain.
The most interesting finding from the docking study is the presence of four ion pairs interacting
between pirin and p65. The R-shaped surface residues Arg14, Arg23, Glu32, and Lys34 of ferric pirin are
electrostatically complemented by p65 residues Glu279, Glu282, Arg273 and Glu234 at distances of 3.2,
2.7, 3.0, and 3.5 Å, respectively, forming four ion pairs (Figure 5.13). Interestingly, these four residues
contribute to the major changes of the R-shaped region as shown in Figure 5.4. In contrast, these ion
pair interactions are missing when the Fe(II)-pirin structure is used for docking.

Figure 5.11 Structural differences shown in the alignment of ferric pirin (yellow) (A) with Co(II)substituted pirin (pink), (B) with Mn(II)-pirin (red), and (C) with Mn(III)-pirin (blue). Colored regions
indicate areas of deviation (≥ 1 Å), while grey regions indicate identical structural features.
The R-shaped region was tested by site-directed mutagenesis. R23E, E32V, K34V, and double mutant
S13R/R14W of the R-shaped region mutants were generated and analyzed. These pirin variants were
reconstituted with Fe(II) and oxidized prior to SPR analysis in the same manner as the wild-type protein.
Figure 5.14A shows that these mutations have a significant adverse effect on the binding of pirin to p65
compared to the wild-type protein, reducing the binding efficiency to one to two-thirds of the wild-type.
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While there was less DNA binding in these mutants, the resulting supercomplex was still tightly bound
and showed a similar lack of dissociation as the wild-type. Q115N pirin was generated and used as a
control along with wild-type pirin. Q115 is not part of the R-shaped region. It is located in the interior of
the protein. Not surprisingly, Q115N essentially behaved the same as wild-type pirin. These results
demonstrate that site-directed mutation of the surface loop residues dramatically changes the ability of
pirin to facilitate p65 binding to the κB site and thereby supports the docking model.
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Figure 5.12 A docking model of pirin (green/yellow)-p65 (blue)-IgκB (golden/blue)
supercomplex built from the corresponding crystal structures (see Materials and Methods). The
R-shaped region is highlighted in yellow and the Fe ion is represented in the sphere (ferric in
yellow and ferrous in light green).
An 1.70 Å resolution crystal structure of the E32V mutant was obtained in its oxidized form
(4HLT, Table A5). The structure shows that mutation of Glu32 disrupts the electrostatic interaction
between Glu32 and Arg14 (Figure 5.14B). The two residues are within 3.2 Å in the ferric form of native
pirin, but Val32 and Arg14 are 9.4 Å apart in E32V. Consequently, the position of the guanidinium group
of Arg23 is also shifted. Among the four charged residues, Lys34 is the only residue that is nearly not
affected by mutation. This structure provides a molecular rationale for the negative impact of the
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mutation. Together, these data validate the R-shaped region as the functionally important area of pirin
for interaction with p65.

Figure 5.13 The zoomed-in view of the pirin (top, green)-p65 (bottom, cyan) interface region
shows multiple complementary ion-pair interactions including K34-E234, E32-R273, R14-E279, and
R23-E282 (pirin-p65).
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5.5 Discussion
Based on previous work and this study, it is concluded that pirin is a redox sensor in the cell
nucleus that functions as a co-regulator of NF-κB (109). Figure 5.15 presents an iron-dependent
bioinorganic scheme for how NF-κB could respond to redox changes within the nucleus. Previous studies
have established that NF-κB activation is first achieved by phosphorylation of the inhibitory IκB proteins
in the cytoplasm to liberate NF-κB. Upon translocation of NF-κB to the nucleus, several layers of
activation take place involving different co-regulators and mechanisms. In the nucleus, under normal
reducing conditions, pirin resides in its inactive ferrous state. The results presented here show that,
when the redox environment shifts to more oxidizing conditions, pirin responds by changing to its
functionally active ferric form and turns on the transcription factor. This is a reversible redox process,
depending on the oxidation state of the iron. The dependence of pirin on its iron cofactor is likely an
additional contributing factor to the link between iron and NF-κB in the nucleus.

Figure 5.14 Mutation at the R-shaped surface impairs the ability of pirin to enhance the DNA
binding ability of p65 to the IgκB site. (A) SPR assay using p65 and immobilized IgκB with R23E (black
trace), E32V (cyan), K34V (wine), and S13R/R14W (magenta). The non-surface mutant Q115N (dark
yellow) was used as a positive control, and (B) the crystal structure of E32V aligned with native pirin
structure. Colored regions indicate areas of deviation (≥ 1 Å), while grey regions indicate identical
structural features.
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Figure 5.15 The proposed function of human pirin. This model depicts a non-heme iron- and
oxidation state-dependent regulation mechanism of NF-κB in the cell nucleus.
It remains to be determined whether the proposed non-heme iron protein-based redox switch
operates in vivo. However, our findings are consistent with recent biological studies showing increased
expression of pirin in response to the oxidative stress (92, 110, 111). Interestingly, pirin-like proteins in
plants and prokaryotes have also been linked to stress-induced responses and programmed cell death
(112). Upregulation of pirin expression by chronic cigarette smoking has been associated with bronchial
epithelial cell apoptosis, presumably due to increased oxidative stress that triggers Nrf2-modulated
genes including pirin (110). The conclusion that the oxidation state and activity of pirin is regulated by
cellular redox conditions is consistent with those previous findings proposing a role as a protector
against oxidative stress. Thus, oxidative stress elevates both the expression of pirin and its activity.
When redox levels are restored to normal reducing conditions in the cell nucleus, the transcriptional
response induced by pirin may be ablated by reducing its expression and by losing its ability to form a
complex with NF-κB and DNA. However, the present work does not exclude the possibility that there is
another protein responsible for oxidizing pirin in the nucleus as a part of a signaling cascade.
Pirin has been proposed to be an important factor in cell differentiation (113). In progenitor
cells, the activation of pirin is an important event that alters the transcription profile of the cell to one
that primes the cell for differentiation (113). Reduced pirin expression is a common feature of acute
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myelogenous leukemia, which results in the proliferation of immature myeloid cells. Elevation in the
concentration of reactive oxygen species (ROS) has been reported to facilitate differentiation in
hematopoetic progenitor cells (114).
Pirin utilizes a structure-based conformational switch to quickly, reversibly, and efficiently
inform the transcription factor of the positive/negative shift of redox levels in the nucleus. The data
presented here suggests that the Fe center in pirin is not its active site. Instead, the role of the Fe center
is allosteric control. The R-shaped surface loop region is the site that interacts with p65. The two distinct
conformational states on the R-shaped surface loop regions endow pirin with the ability to regulate NFκB with full reversibility. This unique property distinguishes pirin from any other redox regulators of
transcription factors, including the H2O2 sensor PerR found in a bacterial source (115). PerR and pirin are
both redox sensors with a similar dependence on non-heme iron. Unlike human pirin, PerR itself is a
transcription factor. The Fe ion of PerR participates in a Fenton-type reaction with H2O2. The result of
this reaction is the formation of a hydroxyl radical that irreversibly oxidizes one of its histidine metalbinding ligands resulting in a drastically altered protein conformation that is no longer able to bind to
DNA (115, 116). In contrast, the regulatory mechanism of redox sensing illustrated in Figure 5.15 utilizes
a reversible Fe(II)/Fe(III) oxidation state coupling and a consequent reversible conformational switch.
The conformational variation of the R-shaped loop areas of pirin can respond accordingly to the
oxidation level in cell nucleus, which allows pirin to respond to redox potential shifts in both directions.
5.6 Further Experimental Details
5.6.1 Material preparations
Cloning, expression, and purification of recombinant human pirin: The full-length (1- 290 amino
acids) untagged form of human pirin was cloned and expressed in Escherichia coli strain BL21(DE3)
(Invitrogen). Cells were grown at 37°C in LB media with 50 μg/ml kanamycin until an OD600 around 0.6 0.8 was achieved. Protein expression was induced by 0.4 mM isopropyl-β-D-thiogalactopyranoside. Cells
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were further grown for 16 hours at 28°C before harvesting by centrifugation at 8000 x g for 15 min. The
cells were re-suspended in the lysis buffer (15 ml per gram cell pellet), which consisted of 20 mM HEPES
(pH 7.5), 150 mM NaCl, 2 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride and 10 mM βmercaptoethanol, 5% glycerol. The cell membrane was broken by an automated Cell Disruptor made by
Microfluidics (M-110P) to release proteins. After centrifugation at 27000 x g for 30 min, the crude
extract supernatant was subjected to ammonium sulfate fractionation. The fraction containing the
target protein was re-dissolved in 20 mM MOPS (pH 6.5) buffer and desalted by a HiLoad G-25 column
(2.6 x 30 cm). Pirin was purified from the desalted elute to homogeneity through three subsequent
major chromatographic separation steps (Hi-Load 2.6 x 20 cm SP-Sepharose, Hi-Load 1.6 x 60 cm
Superdex 75, and Mono S 4.6/100 PE columns, respectively) in the MOPS buffer on an ÅKTA Protein
Purifier system.
Preparation of apo-pirin: Metal-free (apo) pirin utilized in the SPR experiment was isolated from
an iron-depleted minimum medium(96). The purified protein was treated with 10 equivalents of EDTA
overnight and then desalted with 20 mM Tris-HCl buffer (pH 7.4) containing 50 mM NaCl and 5%
glycerol. The isolated protein was confirmed to be metal-free by ICP-OES spectrometry.
Metal Ion Reconstituted Pirin: Co(II), Mn(II), and Ni(II) (0.5 mM) were incubated with apo-pirin (0.05
mM) in 20 mM Tris-HCl buffer (pH 7.4) containing 50 mM NaCl. The reconstitution reaction was allowed
to proceed followed by a final desalting step to remove free ions. The Co(II)-, Mn(II)-, and Zn(II)reconstituted pirin proteins were concentrated to ~ 1 mM stock solution for further use.
The Fe(II) reconstitution reaction was initially carried out in an anaerobic chamber (COY
Laboratory Products, Inc., Michigan). Apo-pirin (0.05 mM) was incubated with 1.2 equivalents of
ammonium iron(II) sulfate (i.e., Mohrs salt) in a reaction vial under O2-free conditions. The reaction vial
was sealed with a rubber cap and parafilmed before being removed from the chamber. It was placed in
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an ice bucket overnight with gentle stirring. The reconstituted protein was used without further
desalting to minimize potential oxidation.
Preparation of Fe(III)- and Mn(III)-pirin: The oxidation of Fe(II)-pirin to Fe(III)-pirin was achieved by
using an excess of potassium ferricyanide (5:1 ratio). After 4 hours of incubation, the protein was
desalted to remove the oxidant. Ferric pirin shows a pale yellow color, in contrast to the colorless Fe(II)
oxidation state. Likewise, oxidation of Mn(II)-pirin to Mn(III) was achieved similarly with the exception of
a longer incubation time (overnight). The change of the oxidation state of pirin was confirmed by low
temperature EPR spectroscopy measured before and after the oxidation reaction.
Site-directed mutagenesis of pirin: The point mutants of pirin were generated by using the QuikChange
II kit (Qiagen). The forward primer sequences used for site-directed mutagenesis were as follows
(mutation sites are underlined):
R23E:

5’-GAAGGGGTTGGAGCGGAGGTCCGGAGAAGCATT-3’

E32V:

5'-AGCATTGGCAGACCCGTGTTAAAAAATCTGGAT-3'

K34V:

5’-GGCAGACCCGAGTTAGTGAATCTGGATCCGTTT-3’

Q115N:

5’-CATGGCCTAAACCTGTGGGTT-3’

S13R/R14W:

5’-AGTGCTCAGGTGGGAGCAGTC-3’

The sequences of the mutants were verified by DNA sequencing prior to expressing and purifying
proteins. The procedures used for the expression, purification, metal-reconstitution and oxidation of the
pirin variants were the same as described previously for the wild-type protein.
Preparation of p65 and Bcl-3: The expression system of His-tagged human p65 (70 kDa, 21–325 amino
acids) was kindly provided by Dr. Jim Maher (Mayo Clinic College of Medicine). The Bcl-3 expression
plasmid (26 kDa, containing 119 - 359 amino acids that include the ankyrin repeat domains) was a
generous gift from Dr. Ulrich Siebenlist (National Institutes of Health). All these proteins were expressed
in E. coli strain BL21 and purified on an ÅKTA Protein Purifier system (GE Healthcare, NJ) according to
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previously published procedures with minor modifications including using Cell Disruptor (Microfluidics,
M-110P) for breaking cell membrane and high capacity and high resolution resins in subsequent
chromatographic separation steps (94, 117).
DNA preparation: The κB-site DNA used in the SPR experiments was oligonucleotide 5’-biotinGAGTTGAGGGGACTTTCCCAGGC-3’ (The NF-κB binding site, IgκB site, are highlighted in bold). These
sequence-specific oligonucleotides and their respective complementary counterparts were synthesized
by Integrated DNA Technologies, Inc (Coralville, Iowa). The single strand DNA was annealed to its
complementary strand before use.
5.6.2 Method description
Surface plasma resonance (SPR) measurement with isolated proteins: Biotinylated IgκB-site DNA
was immobilized to streptavidin-coated sensor chips using standard procedures and sensorgrams were
generated using a Biacore T200 (GE Healthcare). The protein-DNA binding was carried out at 20 °C in 20
mM Tris-HCl, (pH 7.4), containing 50 mM NaCl and 0.005% surfactant P20 at a 50 µl/min flow rate. Each
sensor chip contained four channels. The first and third of which were reference channels that did not
contain immobilized DNA and they were used for a blank baseline reading that was subtracted from
each measurement presented in the sensorgrams (channel #2 – #1 and channel #4 – #3, respectively).
The second channel was used to study protein binding to IgκB-site DNA and the last channel was an
additional control by which a non-specific DNA sequence of 5’-CCTATATGCGGCGTATATCC-3’ was
immobilized (1000 RU, about 1 ng/mm2 of protein or DNA (118)). The effect of pirin upon NF-κB binding
the IgκB sequence was studied by flowing the protein over the sensor chip and comparing the levels of
DNA binding in the absence and presence of the putative co-regulator protein. The final concentration
of p65 and p50 was 50 nM in the SPR injection buffer while pirin’s concentration was varied from 0 - 25
µM. In the p50 experiment, Bcl-3 was included at a concentration of 25 nM. After injecting protein
samples for 420 seconds, buffer was injected from 420 - 1220 s to rinse the weakly bound proteins from
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the chip surface in order to monitor the dissociation of the protein or protein complexes. Vitamin C was
injected at 980 s in the reversibility testing experiments. The sensor chip surface was regenerated with
0.1% SDS and 3 mM EDTA between each measurement.

SPR measurements under anaerobic conditions: To perform anaerobic Biacore experiments
involving the aforementioned Fe(II)-pirin, the SPR system was primed with O2-free, argon-saturated 20
mM Tris-HCl buffer (pH 7.4), containing 50 mM NaCl and 0.005% surfactant P20 at least 4 times over half
an hour. All the proteins, including Fe(II)-pirin, were pre-treated in sealed reaction vials attached to a
Schlenk line by 20 – 30 gentle vacuum/argon cycles with stirring at 4 °C. The SPR experiments were
conducted with the argon-saturated buffer at 20 °C.
SPR measurements with HeLa cell-free nuclear extract: Nuclear extract of HeLa cells was prepared by
using the subcellular protein fractionation kit for cultured cells from Pierce Protein Research Products
(part of Thermo Fisher Scientific, Rockford, IL), according to the manufacturer's protocols. Prior to
injection, the extract was diluted to 0.08 µg/mL by the SPR binding buffer described above. The binding
measurements were taken with the extract alone and together with added pirin (10 µM) protein.
Analysis of the SPR data: In the absence of pirin, the data of NF-κB binding to the IgκB sequence was
fitted by the following one-phase exponential association equation (eq.1) for calculating the binding rate
constant (Kon):

R(t) = Rmax × (1 - exp(-Kon × t))

(eq. 1)

where t represents injection time and R represents response unit.
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In the presence of pirin, the binding curve in the sensorgrams exhibited a two-phase association pattern.
The data of NF-κB binding was fitted to the following two-phase exponential association equation (eq. 2)
for calculating the binding rate constants (Kon1 and Kon2, respectively):

R(t) = Rmax1 × (1 - exp(-Kon1’× t)) + Rmax2 × (1 - exp(-Kon2’ × t))

(eq. 2)

The ferric pirin-induced p65 binding to the immobilized DNA is tight, so much so that virtually no
significant dissociation was observed up to 72 h of continuous buffer injection and rinsing.
Quartz crystal microbalance-dissipation (QCM-D) analyses: Biotin-functionalized sensors were
purchased from Q-Sense (Sweden). Streptavidin was flowed over the biotinylated surface, followed by
biotin-labeled IgκB-site DNA for immobilization. The equilibrium buffer was 20 mM Tris-HCl (pH 7.4)
containing 50 mM NaCl. The QCM-D experiments were carried out with freshly prepared proteins after
both frequency and dissipation baselines were stabilized. Simultaneous measurement at multiple
frequency overtones of the quartz crystal was conducted but only the data obtained with overtone n = 5
were taken for representation. For each measurement, a total volume of 500 µl was continuously
injected at a flow rate of 150 µl/min followed by buffer injection for an additional 300 seconds. The net
change in frequency and dissipation was calculated by subtracting the values recorded at the sample
injection time from those recorded at the end of each rinsing step. This eliminated the influence of
nonspecific, loosely bound proteins on the DNA-immobilized surface. The surface was regenerated
between each sample injections by flowing through 0.05% SDS, followed by the equilibrium buffer until
the baseline was restored. The concentration of p65 was maintained at 0.5 µM, while pirin’s
concentration varied from 0, 0.5, 1.5, 2.5 and 5 µM for each run of the sample application.
Fluorescence spectroscopy: The FAM-labeled double stranded DNA containing the IgκB
sequence (see DNA preparation: section) was added at a final concentration of 20 nM to a
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fluorescence cuvette with 0.5 ml binding buffer of 20 mM Tris-HCl (pH 7.4) and 50 mM NaCl.
Purified p65 was then titrated into the fluorescence cuvette in the presence or absence of
Fe(III)-pirin, or pirin reconstituted with other metal ions. Each measurement was performed
after 10 min of incubation to allow for complete protein-protein and protein-DNA interactions.
The fluorescence measurements were performed on a Cary Eclipse fluorescence
spectrophotometer (Varian, part of Agilent technologies Inc, CA) with an excitation wavelength
of 490 nm, an emission wavelength of 520 nm, and a slit width of 10 nm.
Electrochemical study of Pirin by cyclic voltammetry: The midpoint redox potential of pirin was
determined by using a single-wall carbon nanotube-modified electrode in a spectroelectrochemical cell
hosted in a N2-filled, O2-free plastic bag. Pirin (500 µM) in 50 mM Tris-HCl (pH 7.4) was used in this
study. The formal potential was obtained from the recorded cyclic voltammetry curves and reported in
millivolts versus Ag/AgCl reference.
Electronic paramagnetic resonance (EPR) spectroscopy: X-band EPR spectra were obtained in
perpendicular mode on a Bruker (Billerica, MA) EMX or E200 spectrometer at 100-kHz modulation
frequency using a high sensitivity resonator ER4119HS. Low temperature (10 K) was maintained with an
ITC503S temperature controller, an ESR910 liquid helium cryostat, and LLT650/13 liquid helium transfer
tube (Oxford Instruments, Concord, MA). Measurements were conducted by maintaining the frequency
of the electromagnetic radiation constant while the magnetic field was swept. Pirin (160 µL/sample, 200
– 450 µM) was prepared in quartz EPR tube with 20 mM Tris-HCl buffer (pH 7.4) containing 50 mM NaCl.
Inductively coupled plasma optical emission spectrometry (ICP-OES): Metal contents of each pirin
sample were determined by using a Spectro Genesis spectrometer (Spectro Analytical Instruments
GmbH & Co. KG, Germany). Calibration curves were obtained by measuring the standards at the
concentrations of each element at 0, 0.1, 0.3, 0.5, 1.0 and 10 ppm (mg/L).
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Crystallizations and X-ray structure determinations: Pirin was crystallized through optimization of the
conditions previously established (12) by hanging drop vapor diffusion in VDX plates (Hampton
Research). Single crystals suitable for X-ray data collection were obtained from drops assembled with 1
μL protein solution layered with 1 μL reservoir solution containing 0.1 M MOPS pH 6.5, 15% PEG 20000.
Crystal growth took place in a vibration-free crystal growth refrigerator from Molecular Dimensions at
16 °C. The crystals were mounted in small loops of fine rayon fiber and flash-cooled directly in liquid
nitrogen after being dipped into the cryoprotectant solution that contained 0.1 M MOPS pH 6.5, 17%
PEG 20000 and 30% ethylene glycol. Initial screening was carried out using a Rigaku MicroMax 007 HF
Cu-rotating anode X-ray generator, operated at 40 V and 30 mA, and utilizing a Saturn 944 CCD area
detector. X-ray diffraction data were collected by either the Rigaku X-ray facility at Emory University or
at the SER-CAT beamline 22-ID of the Advanced Photon Source (APS), Argonne National Laboratory,
Argonne, IL. All data collection was performed at 100 K. The diffraction data were indexed, integrated
and scaled with HKL2000 (37). The structures were solved by molecular replacement using MOLREP
program (56) of the CCP4 suite (39) with Fe(II)-pirin structure (PDB accession number 1J1L) (12) as
search model. Electron density was fit and refined using Coot (40), REFMAC (42) and PHASER (97).
Figures showing crystal structures were drawn with PyMOL (http://ww.pymol.org).
In Silico modeling of the supercomplex: Rigid docking of pirin with p65 was conducted using the ZDOCK
utility and server (http://zdock.umassmed.edu) (98). The PDB files of ferric pirin (PDB accession number
4EWA) and p65 (1RAM) (99) were used in model building. The following assumption was applied to the
in silico model search: the interacting region is located on the C-terminal domain of the RHD of p65. This
was based on the experimental observations that pirin facilitates both p50’s and p65’s DNA binding
ability to a target gene. It is known that Bcl-3 interacts with the C-terminal domain of p50, near the
dimerization interface (119). Pirin is not big enough to be able to interact with both the N-terminal
domain and Bcl-3 at the same time. Therefore, pirin can only be located at the C-terminal domain in
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close contact with Bcl-3. Especially since it has been shown that all seven ankyrin repeats of Bcl-3 are
needed for the interaction between pirin and Bcl-3 (87), the C-terminal domain is the most likely region
for pirin to bind. Since a similar DNA binding enhancement effect is seen with p65, it is reasonable to
assume that the C-terminal domain is being acted upon. Out of the models generated by ZDOCK with
the constraint that pirin must interact with the C-terminal domain of the RHD of p65, the top-ranked
result shown in Figure 6 involves the R-shaped area of pirin, which has been shown in the structural
study to differ in conformation when the metal oxidation state changes or metal substitution occurs.
The trend of the conformation changes are all the same, i.e., loops moving to one position over the
other, when pirin becomes inactivated. Finally, the modeling results were further tested by site-directed
mutagenesis experiments.
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Table 2. X-ray crystallography data collection and refinement statistics of ligand-free, ligand bound-and Fe-bound intermediates of HAO.
Data collection

wild-type

3-HAA
bidentate
bound
MAR
300 CCD

Superoxo-bound

300 CCD

3-HAA
monodentate
bound
MAR
325 CCD

0 CCD

CCD

325 CCD

R325 CCD

25 CCD

APS,
Sector 22-ID

APS,
Sector 22-BM

APS,
Sector 22-ID

APS,
Sector 22-ID

APS,
Sector 22-BM

APS,
Sector 22-BM

APS,
Sector 22-BM

APS,
Sector 22-BM

P652

P6522

group

P6522

P6522

2

Unit
cell lengths (Å)

= 58.340,

Detec
tor type
Sourc
e

MAR

Space

a= b
= 57.961,

c=
Unit
cell angles (˚)

MAR30

P652

a= b

c=

c=

a= b=
58.153,

c=

c=

231.426

232.079

230.843

232.518

232.656

α=β
= 90 º, γ = 120º

α=β
= 90 º, γ = 120º

α=β
= 90 º, γ = 120º

α=β=
90 º, γ = 120º

α = β = 90
º, γ = 120º

Wavel

1.00

1.00

1.00

1.00

1.00

Temp
erature (K)

100

100

100

100

100

all-trans
ACMS-bound
MAR

P6522

a= b=
58.567,

epoxidebound

MAR325

P6522

a= b
= 58.235,

Alkylperoxo-bound

2,3-cis-4,5-trans
ACMS-bound

MA

P652
2

2

a=
b = 58.279,
c=
231.647
α=β
= 90 º, γ =
120º
1.00

a=
b = 58.708,
c=
232.045
α=
β = 90 º, γ =
120º
1.00

MAR3

a= b=
58.299,
c=
231.116
α=β=
90 º, γ = 120º
1.00

ength (Å)

Resol
ution (Å)

a

50.0
0 – 1.75

45.00
– 2.40

(1.78
– 1.75)
Compl
a
eteness (%)

(%)

96.9

Rmerge

a, b

a

(2.54 –

99.2

13.8

11.5
(39.6)

(2.44

77.1

(2.1

89.3

10.7
(44.1)

(2.34
– 2.30)

97.3
(75.0)

11.3
(44.7)

35.00
– 2.30

0 – 2.06)

(45.1)

100

50.0
0 – 2.06

– 2.40)

(40.1)

100

35.0
0 – 2.40

2.50)

(88.9)

(61.5)

89.0
(47.5)

10.5
(35.5)

17.7
(93.3)

28.1
(4.1)

25.4

(3.0)
Redun
a

(2.04 –

81.6

12.1

35.00 –
2.50

2.01)

(32.5)

(37.4)

67.2

dancy

(2.75

82.2

8.7

50.00 –
2.01

– 2.70)

(40.5)

(47.4)
I/σI

(2.44
– 2.40)

(76.8)

45.0
0 – 2.70

100

(1.9)
23.0

(10.0)

27.2
(12.8)

57.7

13.0
(4.7)

15.6 (1.8)

(3.0)
21.7
(8.8)

31.2
(2.6)

3.9 (3.4)

31.7
(1.9)

15.4
(0.8)

20.8
(9.2)

26.9
(12.7)

12.7
(2.5)
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Re
finement
Re
solution (Å)
No
. reflections;
working/test

ork

ee

(%)

(%)

c

d

Rw

Rfr

wild-

3-HAA
monodentate
bound

type

1.74

2.40

24184 /
1239
0.21

7879 /
379
0.24

0.25

3-HAA
bidentate bound

2.71

5388 /
257
0.24

Super
oxo-bound

2.01

15595
/ 829
0.20

Alkylper
oxo-bound

2.50

7522 /
356
0.24

epoxid
e-bound

2.40

8790 /
433
0.23

alltrans ACMSbound

2,3cis-4,5-trans
ACMS-bound

2.06

15069
/ 755
0.24

0.31

0.35

0.26

0.30

0.31

0.30

97.09

88.82

95.93

90.12

93.02

95.93

2.30

9426
/ 476
0.25

0.30

e

Ramachandran statistics
97.67
Preferred
(%)

94.1
9

2.33

2.33

7.06

4.07

9.30

4.65

4.07

4.07

Allowed (%)
Root mean square deviation

Bond
lengths (Å)

0.007

0.02

0.11

0.007

0.04

0.009

0.008

0.01

Bond angles
(˚)
PD
B access
code

1.17

1.17

1.58

1.17

1.29

1.27

1.20

1.32

4L2N

4L2P

4L2VP

4L2Q

4L2R

4L2S

4L2T

4L2U
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Table 3. X-ray crystallography data collection and refinement statistics of
HAD bound with different with different small compounds.
Data collection
Detector type
Source
Space group
Unit cell lengths (Å)
Unit cell angles (˚)
Wavelength (Å)
Temperature (K)
Resolution (Å)a
Completeness (%)a
Rmerge (%)a, b
I/σI a
Redundancya
Refinement
Resolution (Å)

FeCu-HAO

CuFe-HAO

MAR225 CCD
APS, Sector 22-BM
P6522

MAR300 CCD
APS, Sector 22-ID
P6522

a = b = 57.70,
c = 232.01

a = b = 58.52,
c = 230.25

α = β = 90 º, γ =
120º
1.00
100
45.00 – 2.80
(2.85 – 2.80)
82.9 (22.7)
8.8 (35.4)
30.6 (3.1)
16.1 (10.5)

α = β = 90 º, γ =
120º
1.0
100
45.00 – 1.75
(1.78 – 1.75)
98.2 (84.3)
11.2 (60.6)
51.6 (2.5)
25.3 (13.7)

2.81

1.75

No. reflections;
4970/224
working/test
Rwork (%)c
22.1
d
Rfree (%)
32.6
Ramachandran statisticse
Preferred (%)
86.2
Allowed (%)
10.5
Root mean square deviation
Bond lengths (Å)
0.008
Bond angles (˚)
1.170
PDB access code
4HVQ
Estimated overall coordinate error
Esu based on R
0.51
value
Esu based on free R
0.30
value

23111/1242
21.4
24.2
97.7
2.3
0.027
2.274
4HVO
0.113
0.110
a

Values in parentheses are for the highest resolution shell.
b
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average
intensity of multiple measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is
the calculated structure factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.
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Table 4. X-ray crystallographic data collection and refinement statistics of human pirin at the
active ferric oxidation state
Data Collection

Detector type
Source
Space group
Unit cell lengths

Ferric Pirin

Ferric Pirin

(Synchron)
MAR300 CCD
APS, Sector 22ID
P212121
a = 42.30, b =
67.03,

(in-house
facility)
Saturn 944 CCD
Cu Rotating
Anode
P212121
a = 42.17, b =
66.70,

c = 107.06
α = β = γ = 90º
0.80
100
21.88 – 1.80

c = 106.21
α = β = γ = 90º
1.54
100
50.00 – 2.48

(1.85 – 1.80)
99.5 (94.3)
14.9 (47.5)
32.9 (3.6)
9.6(3.8)
1.80

(2.52 – 2.48)
89.5 (75.0)
13.1 (52.4)
21.4 (3.8)
5.5 (4.7)
2.47

25931/1397

9419/480

18.7
23.4
96.15
2.80
0.022
2.258
4GUL

24.0
29.6
92.66
5.94
0.006
1.091
4EWA

0.029

1.752

0.028

0.382

(Å)
Unit cell angles (˚)
Wavelength (Å)
Temperature (K)
Resolution (Å)a
a

Completeness (%)
Rmerge (%)a, b
I/σI a
Redundancya
Resolution (Å)
No. reflections;
working/test
Rwork (%)c
Rfree (%)d
Preferred (%)
Allowed (%)
Bond lengths (Å)
Bond angles (˚)
PDB access code
Esu based on R
value
Esu based on free
R value
a

Values in parentheses are for the highest resolution shell.
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average
intensity of multiple measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is
the calculated structure factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.
b
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Table 5. X-ray crystallographic data collection and refinement statistics of metal-substituted
pirin variants
Data Collection
Co(II)-Pirin
Mn(II)-Pirin
Mn(III)-Pirin
Detector type
Saturn 944
MAR300 CCD
Saturn 944
Emory, Cu Rotating
APS, Sector
Emory, Cu
Source
Anode
22-ID
Rotating Anode
P212121
P212121
Space group
P212121
a = 42.13, b = 66.25,
a = 42.16, b =
a = 42.33, b =
Unit cell lengths (Å)
c = 106.13
67.03, c = 107.16
67.07, c = 107.75
Unit cell angles (˚)
α = β = γ = 90º
α = β = γ = 90º
α = β = γ = 90º
Wavelength (Å)
1.54
0.80
1.54
Temperature (K)
100
100
100
35.00
2.50
50.00
1.56
50
- 2.07
Resolution (Å)a
(2.54 - 2.50)
(1.59 - 1.56)
(2.11 – 2.07)
Completeness (%)a
84.1 (75.0)
98.2 (97.5)
88.1 (71.2)
Rmerge (%)a, b
11.6 (54.6)
7.7 (59.3)
19.3 (80.8)
a
I/σI
9.4 (1.6)
25.3 (2.5)
10.4 (1.9)
Redundancya
3.7 (3.5)
6.9 (6.4)
9.7 (7.7)
Refinement
Resolution (Å)
2.65
1.56
2.15
No. reflections;
7038/363
41074/2179
14201/716
working/test
c
Rwork (%)
19.2
13.5
20.4
Rfree (%)d
23.5
16.7
23.4
Ramachandran statisticse
Preferred (%)
91.36
96.45
95.10
Allowed (%)
5.94
2.96
3.85
Root mean square deviation
Bond lengths (Å)
0.014
0.026
0.019
Bond angles (˚)
0.927
2.289
1.692
PDB access code
4ERO
4EWE
4EWD
Estimated overall coordinate error
Esu based on R value
0.082
0.017
0.079
f
Esu based on free R
0.049
0.176
0.014
value
a
Values in parentheses are for the highest resolution shell.
b
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average
intensity of multiple measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is
the calculated structure factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.
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Table 6. X-ray crystallographic data collection and refinement statistics of ferric E32V pirin
variant
Data Collection
Detector type
Source
Space group
Unit cell lengths (Å)
Unit cell angles (˚)
Wavelength (Å)
Temperature (K)
Resolution (Å)a

E32V-Pirin
MAR300 CCD
APS, Sector 22-ID
P212121
a = 42.41, b =
66.64,
c = 107.33
α = β = γ = 90º
1.0
100
31.84 – 1.70
(1.73 – 1.70)
97.1 (79.8)
7.4 (38.4)
55.3 (4.0)
12.2 (6.0)

Completeness (%)a
Rmerge (%)a, b
I/σI a
Redundancya
Refinement
Resolution (Å)
1.70
No. reflections;
31298/1677
working/test
Rwork (%)c
18.4
d
Rfree (%)
23.4
Ramachandran statisticse
Preferred (%)
96.50
Allowed (%)
1.75
Root mean square deviation
Bond lengths (Å)
0.023
Bond angles (˚)
2.353
PDB access code
4HLT
Estimated overall coordinate error
Esu based on R
0.110
value
f
Esu based on free
0.116
R value
a

Values in parentheses are for the highest resolution shell.
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average
intensity of multiple measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is
the calculated structure factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.
b

99

REFERENCES
1.

J. M. Dunwell, Cupins: a new superfamily of functionally diverse proteins that include germins
and plant storage proteins. Biotechnol. Genet. Eng. Rev. 15, 1 (1998).

2.

J. M. Dunwell, A. Purvis, S. Khuri, Cupins: the most functionally diverse protein superfamily?
Phytochemistry 65, 7 (2004).

3.

S. Khuri, F. T. Bakker, J. M. Dunwell, Phylogeny, function, and evolution of the cupins, a
structurally conserved, functionally diverse superfamily of proteins. Mol. Biol. Evol. 18, 593
(April 1, 2001, 2001).

4.

J. M. Dunwell, A. Culham, C. E. Carter, C. R. Sosa-Aguirre, P. W. Goodenough, Evolution of
functional diversity in the cupin superfamily. Trends Biochem Sci 26, 740 (Dec, 2001).

5.

P. L. Roach, I. J. Clifton, V. Fulop, K. Harlos, G. J. Barton, J. Hajdu, I. Andersson, C. J. Schofield, J.
E. Baldwin, Crystal structure of isopenicillin N synthase is the first from a new structural family of
enzymes. Nature 375, 700 (Jun 22, 1995).

6.

E. J. Woo, J. M. Dunwell, P. W. Goodenough, A. C. Marvier, R. W. Pickersgill, Germin is a
manganese containing homohexamer with oxalate oxidase and superoxide dismutase activities.
Nat. Struct. Biol. 7, 1036 (Nov, 2000).

7.

B. Gopal, L. L. Madan, S. F. Betz, A. A. Kossiakoff, The crystal structure of a quercetin 2,3dioxygenase from Bacillus subtilis suggests modulation of enzyme activity by a change in the
metal ion at the active site(s). Biochemistry 44, 193 (Jan 11, 2005).

8.

R. A. Steiner, K. H. Kalk, B. W. Dijkstra, Anaerobic enzyme-substrate structures provide insight
into the reaction mechanism of the copper-dependent quercetin 2,3-dioxygenase. Proc. Natl.
Acad. Sci. U.S.A. 99, 16625 (Dec 24, 2002).

100
9.

B. M. Barney, M. R. Schaab, R. LoBrutto, W. A. Francisco, Evidence for a new metal in a known
active site: purification and characterization of an iron-containing quercetin 2,3-dioxygenase
from Bacillus subtilis. Protein Expr. Purif. 35, 131 (May, 2004).

10.

M. S. Lah, M. M. Dixon, K. A. Pattridge, W. C. Stallings, J. A. Fee, M. L. Ludwig, Structure-function
in Escherichia coli iron superoxide dismutase: comparisons with the manganese enzyme from
Thermus thermophilus. Biochemistry 34, 1646 (Feb 7, 1995).

11.

Y. Zhang, K. L. Colabroy, T. P. Begley, S. E. Ealick, Structural studies on 3-hydroxyanthranilate3,4-dioxygenase: The catalytic mechanism of a complex oxidation involved in NAD biosynthesis.
Biochemistry 44, 7632 (2005).

12.

H. Pang, M. Bartlam, Q. Zeng, H. Miyatake, T. Hisano, K. Miki, L.-L. Wong, G. F. Gao, Z. Rao,
Crystal structure of human Pirin. J. Biol. Chem. 279, 1491 (January 9, 2004).

13.

E. L. Hegg, L. Que, Jr., The 2-His-1-carboxylate facial triad--an emerging structural motif in
mononuclear non-heme iron(II) enzymes. Eur. J. Biochem. 250, 625 (Dec 15, 1997).

14.

O. Kurnasov, V. Goral, K. L. Colabroy, S. Gerdes, A. S, A. Osterman, T. Begley, NAD biosynthesis:
identification of the tryptophan to quinolinate pathway in bacteria. Chem. Biol. 10, 1195 (Dec.,
2003).

15.

K. L. Colabroy, T. P. Begley, The pyridine ring of NAD is formed by a nonenzymatic pericyclic
reaction. J . Am. Chem. Soc. 127, 840 (2005).

16.

X. Li, M. Guo, J. Fan, W. Tang, D. Wang, H. Ge, H. Rong, M. Teng, L. Niu, Q. Liu, Q. Hao, Crystal
structure of 3-hydroxyanthranilic acid 3,4-dioxygenase from Saccharomyces cerevisiae: A special
subgroup of the type III extradiol dioxygenases. Protein Science 15, 761 (2006).

17.

I. Dilovic, F. Gliubich, G. Malpeli, G. Zanotti, D. Matkovic-Calogovic, Crystal structure of bovine 3hydroxyanthranilate 3,4-dioxygenase. Biopolymers 91, 1189 (2009).

101
18.

E. Bitto, C. A. Bingman, G. E. Wesenberg, G. N. Phillips Jr., Crystal structure of human 3hydroxyanthranilic acid 3,4-dioxygenase from Saccharomyces cerevisiae: A special subgroup of
the type III extradiol dioxygenases. RCSB PDB entry: 2QNK, (2011).

19.

L. D. Eltis, J. T. Bolin, Evolutionary relationships among extradiol dioxygenases. Journal of
Bacteriology 178, 5930 (1996).

20.

E. G. Kovaleva, J. D. Lipscomb, Crystal structures of Fe2+ dioxygenase superoxo, alkylperoxo, and
bound product intermediates. Science 316, 453 (2007).

21.

R. J. Deeth, T. D. H. Bugg, A density functional investigation of the extradiol cleavage mechanism
in non-heme iron catechol dioxygenases. J. Biol. Inorg. Chem. 8, 409 (2003/04/01, 2003).

22.

P. E. M. Siegbahn, F. Haeffner, Mechanism for Catechol Ring-Cleavage by Non-Heme Iron
Extradiol Dioxygenases. J. Am. Chem. Soc. 126, 8919 (2004).

23.

T. Borowski, V. Georgiev, P. E. M. Siegbahn, On the observation of a gem diol intermediate after
O-O bond cleavage by extradiol dioxygenases. a hybrid DFT study. J. Mol. Model. 16, 1673
(2010).

24.

G. J. Christian, S. Ye, F. Neese, Oxygen activation in extradiol catecholate dioxygenases - a
density functional study. Chem. Sci. 3, 1600 (2012).

25.

M. M. Mbughuni, M. Chakrabarti, J. A. Hayden, E. L. Bominaar, M. P. Hendrich, E. Munck, J. D.
Lipscomb, Trapping and spectroscopic characterization of an Fe(III)-superoxo intermediate from
a nonheme mononuclear iron-containing enzyme. Proc. Natl. Acad. Sci. U.S.A. 107, 16788 (Sep
28, 2010).

26.

E. G. Kovaleva, J. D. Lipscomb, Intermediate in the O-O bond cleavage reaction of an extradiol
dioxygenase. Biochemistry 47, 11168 (2008).

102
27.

K. L. Colabroy, H. Zhai, T. Li, Y. Ge, Y. Zhang, A. Liu, S. E. Ealick, F. W. McLafferty, T. P. Begley, The
mechanism of inactivation of 3-hydroxyanthranilate-3,4-dioxygenase by 4-chloro-3hydroxyanthranilate. Biochemistry 44, 7623 (2005).

28.

D. T. Sawyer, R. J. P. Williams, Oxygen Chemistry. (Oxford University Press, 1991).

29.

R. Schwarcz, W. O. Whetsell, Jr., R. M. Mangano, Quinolinic acid: an endogenous metabolite that
produces axon-sparing lesions in rat brain. Science 219, 316 (Jan 21, 1983).

30.

M. F. Beal, N. W. Kowall, D. W. Ellison, M. F. Mazurek, K. J. Swartz, J. B. Martin, Replication of
the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168
(1986).

31.

T. Muraki, M. Taki, Y. Hasegawa, H. Iwaki, P. C. K. Lau, Prokaryotic homologs of the eukaryotic 3hydroxyanthranilate 3,4-dioxygenase and 2-amino-3-carboxymuconate-6-semialdehyde
decarboxylase in the 2-nitrobenzoate degradation pathway of Pseudomonas fluorescens strain
KU-7. App. Environm. Microbiol. 69, 1564 (2003).

32.

T. Li, A. L. Walker, H. Iwaki, Y. Hasegawa, A. Liu, Kinetic and spectroscopic characterization of
ACMSD from Pseudomonas fluorescens reveals a pentacoordinate mononuclear
metallocofactor. J. Am. Chem. Soc. 127, 12282 (Sep 7, 2005).

33.

Y. Nishizuka, A. Ichiyama, R. K. Gholson, O. Hayaishi, Studies on the metabolism of the benzene
ring of tryptophan in mammalian tissues. I. Enzymatic formation of glutaric acid from 3hydroxyanthranilic acid. J. Biol. Chem. 240, 733 (Feb, 1965).

34.

L. W. Chung, X. Li, H. Sugimoto, Y. Shiro, K. Morokuma, ONIOM study on a missing piece in our
understanding of heme chemistry: bacterial tryptophan 2,3-dioxygenase with dual oxidants. J.
Am. Chem. Soc. 132, 11993 (Sep 1, 2010).

103
35.

J. Basran, I. Efimov, N. Chauhan, S. J. Thackray, J. L. Krupa, G. Eaton, G. A. Griffith, C. G. Mowat,
S. Handa, E. L. Raven, The mechanism of formation of N-formylkynurenine by heme
dioxygenases. J. Am. Chem. Soc. 133, 16251 (Oct 12, 2011).

36.

A. Lewis-Ballester, D. Batabyal, T. Egawa, C. Lu, Y. Lin, M. A. Marti, L. Capece, D. A. Estrin, S.-R.
Yeh, Evidence for a ferryl intermediate in a heme-based dioxygenase. Proc. Natl. Acad. Sci.
U.S.A. 106, 17371 (October 13, 2009, 2009).

37.

Z. Otwinowski, W. Minor, Processing of X-ray diffraction data collected in oscillation mode.
Method Enzymol. 276, 307 (1997).

38.

A. Vagin, A. Teplyakov, Molecular replacement with MOLREP. Acta crystallographica. Section D,
Biological crystallography 66, 22 (Jan, 2010).

39.

S. Bailey, The Ccp4 Suite - Programs for Protein Crystallography. Acta crystallographica. Section
D, Biological crystallography 50, 760 (Sep 1, 1994).

40.

P. Emsley, K. Cowtan, Coot: model-building tools for molecular graphics. Acta crystallographica.
Section D, Biological crystallography 60, 2126 (Dec, 2004).

41.

A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, R. J. Read, Phaser
crystallographic software. J. Appl. Crystallogr. 40, 658 (Aug 1, 2007).

42.

G. N. Murshudov, A. A. Vagin, E. J. Dodson, Refinement of macromolecular structures by the
maximum-likelihood method. Acta crystallographica. Section D, Biological crystallography 53,
240 (May 1, 1997).

43.

P. D. Adams, P. V. Afonine, G. Bunkoczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L. W. Hung,
G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C.
Richardson, J. S. Richardson, T. C. Terwilliger, P. H. Zwart, PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta crystallographica. Section D,
Biological crystallography 66, 213 (Feb, 2010).

104
44.

E. G. Kovaleva, J. D. Lipscomb, Versatility of biological non-heme Fe(II) centers in oxygen
activation reactions. Nat. Chem. Biol. 4, 186 (Mar, 2008).

45.

E. G. Kovaleva, M. B. Neibergall, S. Chakrabarty, J. D. Lipscomb, Finding intermediates in the O2
activation pathways of non-heme iron oxygenases. Acc. Chem Res. 40, 475 (2007).

46.

J. C. Spain, Biodegradation of nitroaromatic compounds. Annual review of microbiology 49, 523
(1995).

47.

A. Esteve-Núñez, A. Caballero, J. L. Ramos, Biological Degradation of 2,4,6-Trinitrotoluene.
Microbiology and Molecular Biology Reviews 65, 335 (September 1, 2001, 2001).

48.

T. Grummt, H. G. Wunderlich, A. Chakraborty, M. Kundi, B. Majer, F. Ferk, A. K. Nersesyan, W.
Parzefall, S. Knasmuller, Genotoxicity of nitrosulfonic acids, nitrobenzoic acids, and
nitrobenzylalcohols, pollutants commonly found in ground water near ammunition facilities.
Environmental and molecular mutagenesis 47, 95 (Mar, 2006).

49.

Y. Hasegawa, T. Muraki, T. Tokuyama, H. Iwaki, M. Tatsuno, P. C. Lau, A novel degradative
pathway of 2-nitrobenzoate via 3-hydroxyanthranilate in Pseudomonas fluorescens strain KU-7.
FEMS. Microbiol. Lett. 190, 185 (Sep 15, 2000).

50.

Y. Hasegawa, T. Muraki, T. Tokuyama, H. Iwaki, M. Tatsuno, P. C. Lau, A novel degradative
pathway of 2-nitrobenzoate via 3-hydroxyanthranilate in Pseudomonas fluorescens strain KU-7.
FEMS microbiology letters 190, 185 (Sep 15, 2000).

51.

O. Wiss, The cleavage and oxidation of 3-hydroxyanthranilic acid. Zeitschrift fuer Naturforschung
9b, 740 (1954).

52.

T. Li, J. Ma, J. P. Hosler, V. L. Davidson, A. Liu, Detection of transient intermediates in the metaldependent non-oxidative decarboxylation catalyzed by a-amino-b-carboxymuconate-esemialdehyde decarboxylase. J. Am. Chem. Soc. 129, 9278 (2007).

105
53.

T. Muraki, M. Taki, Y. Hasegawa, H. Iwaki, P. C. Lau, Prokaryotic homologs of the eukaryotic 3hydroxyanthranilate 3,4-dioxygenase and 2-amino-3-carboxymuconate-6-semialdehyde
decarboxylase in the 2-nitrobenzoate degradation pathway of Pseudomonas fluorescens strain
KU-7. Appl. Environ. Microbiol. 69, 1564 (Mar, 2003).

54.

Y. Zhang, K. L. Colabroy, T. P. Begley, S. E. Ealick, Structural studies on 3-hydroxyanthranilate3,4-dioxygenase: the catalytic mechanism of a complex oxidation involved in NAD biosynthesis.
Biochemistry 44, 7632 (May 31, 2005).

55.

E. L. Hegg, L. Que, Jr., The 2-His-1-carboxylate facial triad--an emerging structural motif in
mononuclear non-heme iron(II) enzymes. European journal of biochemistry / FEBS 250, 625 (Dec
15, 1997).

56.

A. Vagin, A. Teplyakov, Molecular replacement with MOLREP. Acta Crystallogr D Biol Crystallogr
66, 22 (Jan, 2010).

57.

P. Emsley, K. Cowtan, Coot: model-building tools for molecular graphics. Acta crystallographica.
Section D, Biological crystallography 60, 2126 (Dec, 2004).

58.

M. Andrejasic, J. Praaenikar, D. Turk, PURY: a database of geometric restraints of hetero
compounds for refinement in complexes with macromolecular structures. Acta
crystallographica. Section D, Biological crystallography 64, 1093 (Nov, 2008).

59.

D. M. Arciero, J. D. Lipscomb, B. H. Huynh, T. A. Kent, E. Munck, EPR and Mossbauer studies of
protocatechuate 4,5-dioxygenase. Characterization of a new Fe2+ environment. The Journal of
biological chemistry 258, 14981 (Dec 25, 1983).

60.

R. Silaghi-Dumitrescu, E. D. Coulter, A. Das, L. G. Ljungdahl, G. N. Jameson, B. H. Huynh, D. M.
Kurtz, Jr., A flavodiiron protein and high molecular weight rubredoxin from Moorella
thermoacetica with nitric oxide reductase activity. Biochemistry 42, 2806 (Mar 18, 2003).

106
61.

I. Moura, P. Tavares, J. J. Moura, N. Ravi, B. H. Huynh, M. Y. Liu, J. LeGall, Purification and
characterization of desulfoferrodoxin. A novel protein from Desulfovibrio desulfuricans (ATCC
27774) and from Desulfovibrio vulgaris (strain Hildenborough) that contains a distorted
rubredoxin center and a mononuclear ferrous center. The Journal of biological chemistry 265,
21596 (Dec 15, 1990).

62.

P. A. Lindahl, S. W. Ragsdale, E. Munck, Mossbauer study of CO dehydrogenase from Clostridium
thermoaceticum. The Journal of biological chemistry 265, 3880 (Mar 5, 1990).

63.

W. H. Orme-Johnson, Iron-sulfur proteins. Structure and function. Annu. Rev. Biochem. 42, 159
(//, 1973).

64.

A. J. Thomson, Iron-sulfur proteins. Top. Mol. Struct. Biol. 6, 79 (//, 1985).

65.

H. Sticht, The structure of small electron-transfer proteins. Recent Res. Dev. Biochem. 1, 1 (//,
1999).

66.

J. Meyer, J.-M. Moulis. (John Wiley & Sons Ltd., 2001), vol. 1, pp. 505-517.

67.

S. Kawasaki, M. Ono, Y. Watamura, Y. Sakai, T. Satoh, T. Arai, J. Satoh, Y. Niimura, An O2inducible rubrerythrin-like protein, rubperoxin, is functional as a H2O2 reductase in an obligatory
anaerobe Clostridium acetobutylicum. FEBS Lett 581, 2460 (5/29/, 2007).

68.

E. D. Coulter, D. M. Kurtz, Jr., A role for rubredoxin in oxidative stress protection in Desulfovibrio
vulgaris: Catalytic electron transfer to rubrerythrin and two-iron superoxide reductase. Arch.
Biochem. Biophys. 394, 76 (//, 2001).

69.

X. Li, M. Guo, J. Fan, W. Tang, D. Wang, H. Ge, H. Rong, M. Teng, L. Niu, Q. Liu, Q. Hao, Crystal
structure of 3-hydroxyanthranilic acid 3,4-dioxygenase from Saccharomyces cerevisiae: a special
subgroup of the type III extradiol dioxygenases. Protein Sci. 15, 761 (Apr, 2006).

70.

R. Sen, D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer
sequences. Cell 46, 705 (1986).

107
71.

R. Sen, D. Baltimore, Inducibility of k immunoglobulin enhancer-binding protein NF-kB by a
posttranslational mechanism. Cell 47, 921 (1986).

72.

J. A. Romashkova, S. S. Makarov, NF-kB is a target of AKT in anti-apoptotic PDGF signalling.
Nature 401, 86 (Sep 2, 1999).

73.

M. Karin, A. Lin, NF-kB at the crossroads of life and death. Nat. Immunol. 3, 221 (Mar, 2002).

74.

Q. Li, I. M. Verma, NF-kB regulation in the immune system. Nat. Rev. Immunol. 2, 725 (2002).

75.

F. E. Chen, D. B. Huang, Y. Q. Chen, G. Ghosh, Crystal structure of p50/p65 heterodimer of
transcription factor NF-kB bound to DNA. Nature 391, 410 (Jan 22, 1998).

76.

S. Ghosh, M. J. May, E. B. Kopp, NF-kB and Rel proteins: evolutionarily conserved mediators of
immune responses. Annu. Rev. Immunol. 16, 225 (1998).

77.

G. Ghosh, G. van Duyne, S. Ghosh, P. B. Sigler, Structure of NF-kB p50 homodimer bound to a kB
site. Nature 373, 303 (Jan 26, 1995).

78.

H. L. Pahl, Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18, 6853
(Nov 22, 1999).

79.

T. D. Gilmore, NF-kB target genes. http://www.bu.edu/nf-kb/gene-resources/target-genes/,
(2008).

80.

K. Gosselin, NF-kB target genes. http://bioinfo.lifl.fr/NF-KB/, (2004).

81.

K. W. Jeong, K. Kim, A. J. Situ, T. S. Ulmer, W. An, M. R. Stallcup, Recognition of enhancer
element–specific histone methylation by TIP60 in transcriptional activation. Nat. Struct. Mol.
Biol. 18, 1358 (2011).

82.

T. D. Merson, M. P. Dixon, C. Collin, R. L. Rietze, P. F. Bartlett, T. Thomas, A. K. Voss, The
transcriptional coactivator Querkopf controls adult neurogenesis. J. Neurosci. 26, 11359 (Nov 1,
2006).

108
83.

A. M. Naar, B. D. Lemon, R. Tjian, Transcriptional coactivator complexes. Annu. Rev. Biochem.
70, 475 (2001).

84.

A. Oeckinghaus, M. S. Hayden, S. Ghosh, Crosstalk in NF-kB signaling pathways. Nat. Immunol.
12, 695 (2011).

85.

F. E. Chen, G. Ghosh, Regulation of DNA binding by Rel/NF-kB transcription factors: structural
views. Oncogene 18, 6845 (Nov 22, 1999).

86.

W. M. F. Wendler, E. Kremmer, R. Förster, E.-L. Winnacker, Identification of Pirin, a novel highly
conserved nuclear protein. J. Biol. Chem. 272, 8482 (March 28, 1997, 1997).

87.

R. Dechend, F. Hirano, K. Lehmann, V. Heissmeyer, S. Ansieau, F. G. Wulczyn, C. Scheidereit, A.
Leutz, The Bcl-3 oncoprotein acts as a bridging factor between NF-kB/Rel and nuclear coregulators. Oncogene 18, 3316 (Jun 3, 1999).

88.

D. Gurmu, J. Lu, K. A. Johnson, P. Nordlund, A. Holmgren, H. Erlandsen, The crystal structure of
the protein YhaK from Escherichia coli reveals a new subclass of redox sensitive enterobacterial
bicupins. Proteins 74, 18 (Jan, 2009).

89.

M. Adams, Z. Jia, Structural and biochemical analysis reveal Pirins to possess quercetinase
activity. J. Biol. Chem. 280, 28675 (August 5, 2005, 2005).

90.

S. Licciulli, C. Luise, G. Scafetta, M. Capra, G. Giardina, P. Nuciforo, S. Bosari, G. Viale, G.
Mazzarol, C. Tonelli, L. Lanfrancone, M. Alcalay, Pirin inhibits cellular senescence in melanocytic
cells. Am. J. Pathol. 178, 2397 (2011).

91.

I. Miyazaki, S. Simizu, H. Okumura, S. Takagi, H. Osada, A small-molecule inhibitor shows that
pirin regulates migration of melanoma cells. Nat. Chem. Biol. 6, 667 (2010).

92.

K. Brzóska, T. M. Stepkowski, M. Kruszewski, Putative proto-oncogene Pir expression is
significantly up-regulated in the spleen and kidney of cytosolic superoxide dismutase-deficient
mice. Redox Rep. 16, 129 (2011).

109
93.

B. Gelbman, A. Heguy, T. O'Connor, J. Zabner, R. Crystal, Upregulation of pirin expression by
chronic cigarette smoking is associated with bronchial epithelial cell apoptosis. Respir Res 8, 10
(2007).

94.

S. E. Wurster, L. J. Maher, 3rd, Selection and characterization of anti-NF-kB p65 RNA aptamers.
RNA 14, 1037 (June, 2008).

95.

Y. Q. Chen, L. L. Sengchanthalangsy, A. Hackett, G. Ghosh, NF-kB p65 (RelA) homodimer uses
distinct mechanisms to recognize DNA targets. Structure 8, 419 (Apr 15, 2000).

96.

B. M. Sjöberg, P. Reichard, A. Gräslund, A. Ehrenberg, The tyrosine free radical in ribonucleotide
reductase from Escherichia coli. J. Biol.Chem. 253, 6863 (October 10, 1978).

97.

A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, R. J. Read, Phaser
crystallographic software. J Appl Crystallogr 40, 658 (Aug 1, 2007).

98.

R. Chen, L. Li, Z. Weng, ZDOCK: an initial-stage protein-docking algorithm. Proteins 52, 80 (Jul 1,
2003).

99.

Y. Q. Chen, S. Ghosh, G. Ghosh, A novel DNA recognition mode by the NF-kB p65 homodimer.
Nat. Struct. Biol. 5, 67 (Jan, 1998).

100.

C. B. Phelps, L. L. Sengchanthalangsy, S. Malek, G. Ghosh, Mechanism of κB DNA binding by
Rel/NF-κB dimers. Journal of Biological Chemistry 275, 24392 (August 11, 2000, 2000).

101.

W. Y. X. Peh, E. Reimhult, H. F. Teh, J. S. Thomsen, X. Su, Understanding ligand binding effects on
the conformation of estrogen receptor α-DNA complexes: A combinational quartz crystal
microbalance with dissipation and surface plasmon resonance study. Biophys. J. 92, 4415 (June
15, 2007).

102.

R. Schreck, H. Zorbas, E.-L. Winnacker, P. A. Baeuerle, The NF-kB transcription factor induces
DNA bending which is modulated by its 65-kD subunit. Nucleic Acids Res. 18, 6497 (November
25, 1990, 1990).

110
103.

N. C. Horton, J. J. Perona, Crystallographic snapshots along a protein-induced DNA-bending
pathway. Proc. Natl. Acad. Sci. U. S. A. 97, 5729 (May 23, 2000).

104.

C. M. Cordas, A. G. Duarte, J. J. Moura, I. Moura, Electrochemical behaviour of bacterial nitric
oxide reductase-evidence of low redox potential non-heme FeB gives new perspectives on the
catalytic mechanism. Biochim Biophys Acta 1827, 233 (Mar, 2013).

105.

C. K. Vance, A. F. Miller, a simple proposal that can explain the inactivity of metal-substituted
superoxide dismutases. J Am Chem Soc 120, 461 (1998/01/01, 1998).

106.

G. D. Fasman, Physical Chemical Data. CRC Handbook of Biochemistry and Molecular Biology
(CRC Press, Cleveland, Ohio, ed. 3rd ed, 1976), vol. 2.

107.

A. Karlsson, J. V. Parales, R. E. Parales, D. T. Gibson, H. Eklund, S. Ramaswamy, Crystal structure
of naphthalene dioxygenase: Side-on binding of dioxygen to iron. Science 299, 1039 (February
14, 2003).

108.

E. G. Kovaleva, J. D. Lipscomb, Crystal structures of Fe2+ dioxygenase superoxo, alkylperoxo, and
bound product intermediates. Science 316, 453 (April 20, 2007).

109.

F. Liu, I. Rehmani, S. Esaki, R. Fu, L. Chen, V. de Serrano, A. Liu, Pirin is an iron-dependent redox
regulator of NF-kB. Proc. Natl. Acad. Sci. U.S.A. 110, 9722 (Jun 11, 2013).

110.

R. H. Hubner, J. D. Schwartz, P. De Bishnu, B. Ferris, L. Omberg, J. G. Mezey, N. R. Hackett, R. G.
Crystal, Coordinate control of expression of Nrf2-modulated genes in the human small airway
epithelium is highly responsive to cigarette smoking. Molecular medicine (Cambridge, Mass.) 15,
203 (Jul-Aug, 2009).

111.

B. A. Mercer, V. Lemaitre, C. A. Powell, J. D'Armiento, The epithelial cell in lung health and
emphysema pathogenesis. Curr. Respir. Med. Rev. 2, 101 (May, 2006).

112.

D. Orzaez, A. J. de Jong, E. J. Woltering, A tomato homologue of the human protein PIRIN is
induced during programmed cell death. Plant Mol. Biol. 46, 459 (Jul, 2001).

111
113.

S. Licciulli, V. Cambiaghi, G. Scafetta, A. M. Gruszka, M. Alcalay, Pirin downregulation is a feature
of AML and leads to impairment of terminal myeloid differentiation. Leukemia 24, 429 (2009).

114.

E. Owusu-Ansah, U. Banerjee, Reactive oxygen species prime Drosophila haematopoietic
progenitors for differentiation. Nature 461, 537 (Sep 24, 2009).

115.

J.-W. Lee, J. D. Helmann, The PerR transcription factor senses H2O2 by metal-catalysed histidine
oxidation. Nature 440, 363 (2006).

116.

D. A. K. Traore, A. E. Ghazouani, L. Jacquamet, F. Borel, J.-L. Ferrer, D. Lascoux, J.-L. Ravanat, M.
Jaquinod, G. Blondin, C. Caux-Thang, V. Duarte, J.-M. Latour, Structural and functional
characterization of 2-oxo-histidine in oxidized PerR protein. Nat. Chem. Biol. 5, 53 (2009).

117.

F. Michel, M. Soler-Lopez, C. Petosa, P. Cramer, U. Siebenlist, C. W. Muller, Crystal structure of
the ankyrin repeat domain of Bcl-3: a unique member of the IkB protein family. EMBO J. 20,
6180 (2001).

118.

E. Stenberg, B. Persson, H. Roos, C. Urbaniczky, Quantitative determination of surface
concentration of protein with surface plasmon resonance using radiolabeled proteins. J. Colloid
Interface Sci. 143, 513 (1991).

119.

F. G. Wulczyn, M. Naumann, C. Scheidereit, Candidate proto-oncogene bcl-3 encodes a subunitspecific inhibitor of transcription factor NF-kappa B. Nature 358, 597 (Aug 13, 1992).

